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ABSTRACT 
 
BENJAMIN F. PIERCE:  THERMALLY-RESPONSIVE POLY(ESTER URETHANE)S 
 
(Under the direction of Dr. Valerie V. Sheares Ashby) 
 
Thermally-responsive materials are quite useful in the biomedical field, but their full 
potential has yet to be realized.  For example, polyurethanes are capable of exhibiting shape-
memory properties, or the ability to change shape upon the application of a stimulus, but only 
a few practical thermally responsive polyurethanes have been reported due to the lack of 
novel starting materials and optimized systems.  This work describes the synthesis of several 
degradable polymers and the characterization of their thermally responsive behavior.  First, 
several amorphous polyester prepolymers are synthesized and incorporated in thermoplastic 
poly(ester urethane)s, which are highly elastic but display impractical thermal properties.  
Their potential as degradable implants is investigated, as well as their bulk and surface 
properties.  These systems are then optimized and tailored for more practical purposes, 
resulting in the synthesis of thermoset elastomers based on poly(1,4-cyclohexanedimethanol 
1,4-cyclohexanedicarboxylate) (PCCD) prepolymers that display a broad range of useful 
mechanical properties, thermal properties, and shape-memory properties.  A novel method 
for controlling a microscopic and nanoscopic topographical shape-memory phenomenon is 
presented.  Finally, the synthesis of amine-functionalized polyesters is presented.  All 
materials are characterized by 1H and 13C NMR, GPC, DSC, TGA, and Instron. 
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1.1 Thermally-Responsive Shape-Memory Polymers 
 
Thermoresponsive shape-memory polymers (SMPs) are able to recover a previously 
determined permanent shape after being fixed (packaged or programmed) in a temporary 
state.1 These materials are packaged by cooling a stressed system below the transition 
temperature (Ttrans), which freezes the material in the temporary state (Figure 1.1).  The 
original, permanent shape can be recovered after heating the system above Ttrans.  
Semicrystalline elastomers utilize the melting temperature as the transition temperature (Tm = 
Ttrans), and the transition temperature for amorphous SMPs is the glass transition temperature 
(Tg = Ttrans).   
 
              Permanent Shape     Temporary Shape                   Permanent Shape 
               
   Packaging          Recovery 
Figure 1.1  Representation of a shape-memory device 
 
There has been a great deal of interest in the fabrication of biomedical SMPs as 
minimally-invasive implants.2,3 Ideally, these materials are biocompatible and demonstrate 
complete recovery near body temperature (37 °C).  A typical recovery process for a 
biomedical device is shown in Figure 1.2, which shows that the permanent shape (bottom 
left) was packaged to a more confined temporary shape for insertion in vivo (top left).  By 
heating the sample above the transition temperature, the sample is able to recover its 
permanent shape (clockwise).  Shape-memory properties are measured using the strain fixity 
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rate (Rf) and strain recovery rate (Rr), which quantify the ability to be packaged and 
recovered, respectively.  Typically, multiple cyclical tests are used to measure the shape-
memory properties of materials.  
 
   
 
   
 
Figure 1.2  Shape-memory cycle for a biomedical SMP (scale bar = 5 mm) 
 
This review discusses the current state of thermoresponsive shape-memory polymers 
and their biomedical applications.  Section 1.2 discusses the first shape-memory systems; 
Section 1.3 discusses the current state of biomedical SMPs; Section 1.4 discusses their 
limitations; and Section 1.5 outlines the dissertation chapters. 
1.2 Early Shape-Memory Materials 
1.2.1 Shape-Memory Metals 
 Typically, shape-memory metals are not suitable as biomedical devices because they 
are toxic.1,4,5 Some exceptions include nickel-titanium alloys, which have been used as dental 
materials and artificial heart components.6-8 However, these alloys are not elastic (εmax = 8%) 
and are used more for their strength than their shape-memory properties.  In order to prepare 
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more elastic shape-memory materials, the shape-memory capabilities of polymers were 
studied.  
1.2.2 Heat-Shrinkable Polymers 
The first thermally-responsive shape-memory polymers were crosslinked 
polyethylene systems known as heat-shrinkable polymers.9 Although heat-shrinkable 
polymers are useful for protecting electrical wires and in insulation applications, they are less 
suitable for biomedical applications.  Heat-shrinkable polymers possess Ttrans values that 
range from 110 – 130 °C, which are too high to induce safe transitions in vivo.2,9,10 Moreover, 
they exhibit only ~70 % recovery,9 which is insufficient for biomedical SMPs that must 
completely recover under the resistance of adjacent tissues and organs.11,12  
1.3 Current Biomedical SMPs 
Thermoplastic and thermoset elastomers are much more suitable for biomedical 
applications than the initial shape-memory materials.  These SMPs are more biocompatible 
than shape-memory metals; possess more suitable Ttrans values than heat-shrinkable 
polymers; and demonstrate good recovery properties.  Furthermore, several thermoplastic 
and thermoset SMPs are degradable and eliminate the need for additional surgeries following 
device implantation.  Section 1.3.1 describes several examples of thermoplastic SMPs and 
Section 1.3.2 describes several examples of thermoset SMPs.  All the SMPs described here 
are degradable and nontoxic. 
1.3.1 Thermoplastic SMPs 
The shape-memory properties of thermoplastic polyurethanes originate from physical 
crosslinks that form due to thermodynamically incompatible hard and soft segments.13 The 
physical crosslinks impart excellent mechanical properties, as ultimate elongation values for 
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polyurethane elastomers are typically on the order of several hundred percent or higher.  For 
example, both Seppälä and Hilborn synthesized amorphous poly(ester urethane)s with high 
elasticity (ε > 1000 %).14,15 
 Thermoplastic polyurethanes are synthesized using a high molecular weight 
prepolymer, diisocyanate, and chain extender.  A number of studies have examined the 
impact of the soft segment,16-23 diisocyanate,17,24-27 and chain extender28-35 on the final 
elastomer properties.  These reagents may be reacted in a two-step process, where chain 
extension occurs after the soft segments has been endcapped with an excess of diisocyanate, 
or a one-step process, where the chain extender and soft segment diol react with diisocyanate.  
All the thermoplastic polyurethanes described here were prepared using the two-step process. 
Hayashi et al. prepared several semicrystalline thermoplastic SMPs by chain 
extending 4,4’-methylenebis(phenyl isocyanate)-endcapped poly(ethylene adipate) 
prepolymers with 1,4-butanediol (Scheme 1; all Schemes show most basic endcapped 
prepolymers [2/1 diisocyanate/diol]).36 Although these materials were semicrystalline, the Tg 
(-5 – 48 °C) was used as the Ttrans.  These materials were highly elastic (εmax = 150 – 300 % at 
Tg + 20 °C); however, these materials exhibited “cyclic hardening”, where the shape-memory 
properties greatly diminished with increasing number of cycles. Lendlein attributed this 
effect to irreversible slipping of chains, disentangling of mechanical entanglements, and a 
partial breakage of the crystalline hard segments.1 
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Scheme 1.  Thermoplastic SMP prepared by Hayashi et al. 
 
 Kim et al. prepared semicrystalline poly(ε-caprolactone)-based thermoplastic 
urethanes using 4,4’-methylenebis(phenyl isocyanate) (MDI) and 1,4-butanediol with Tm = 
44 – 50 °C (Scheme 2).37  These materials were highly elastic (ε > 1000 %) but also exhibited 
cyclic hardening, which Kim attributed to the poly(caprolactone) chains relaxing in the 
stretched, temporary states.   
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Scheme 2.  Thermoplastic SMPs prepared by Kim et al. 
 
Jing et al. investigated the use of poly(ε-caprolactone) soft segments as well but used 
2,4-toluene diisocyanate (TDI) as the diisocyanate (Scheme 3).38 These semicrystalline 
poly(ester urethane)s displayed excellent shape-memory properties (Tm = 50 – 62 °C and Rr = 
94 – 100%).  These systems are exemplary examples of thermoplastic biomedical SMPs 
because they were degradable, highly elastic (εmax = 300 %), and able to recover at 37 °C 
(Ttrans = 37 – 42 °C). 
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Scheme 3.  Thermoplastic SMP prepared by Jing et al. 
  
As demonstrated by the work of Kim and Jing, the choice of diisocyanate affects the 
mechanical properties of thermoplastic polyurethanes. However, the ratio of hard segment to 
soft segments has a much more profound effect on the shape-memory properties (10 – 45 wt 
% and 6 – 61 wt % were reported by Kim and Jing, respectively).37,38  Full recovery is 
typically seen in thermoplastic polyurethanes with high hard segment ratios (67 – 95 wt %);1 
however, these systems are inelastic.  Typically, thermoplastic polyurethanes are more useful 
in biomedical applications for their elastic properties rather than their shape-memory 
properties.17 For example, semicrystalline poly(urea-urethane)s that are comprised of 
poly(tetramethylene oxide), MDI, and diamine chain extenders have been used in an artificial 
heart (BiomerTM; G = 31 – 41 MPa, εmax = 600 – 800 %, Scheme 4), and the corresponding 
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aliphatic polyurethanes have been used as wound dressing (TecoflexTM; G = 42 MPa and εmax 
= 580 – 800 %, Scheme 4).17 
O
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OCN CH2 NCO+
H2N
NH2
Biomer
HO
O
O
O
NH CH2 NCO
O
n
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O
H
n
OCN CH2 NCO+
HO
OH
Tecoflex
HO
O
O
O
NH CH2 NCO
O
n
HNH2COCN
Scheme 4.  The synthesis of BiomerTM and TecoflexTM 
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A different approach to synthesizing thermoplastic SMPs is the ring opening 
polymerization of lactides, lactones, and cyclic carbonates.  Zini and Scandola prepared 
amorphous (L-lactide-glycolide-trimethylene carbonate) terpolymers with Tg = 12 – 42 °C 
and Rr = 89 – 95 % at ε = 100 % (Scheme 5).39 Similar to thermoplastic polyurethanes, the 
recovery of these materials was highly dependent on chain entanglement and was affected by 
chain slippage. 
 
Scheme 5.  The synthesis of thermoplastic SMP terpolymers by Zini and Scandola 
 
Langer prepared a novel class of semicrystalline SMPs with two melting temperatures 
that avoided the drawbacks of typical thermoplastic SMPs (Scheme 6).3  These systems were 
based on physically crosslinked oligo(ε-caprolactone)diol and oligo(p-dioxanone)diol 
segments, where the oligo(p-dioxanone)diol segments possessed a higher melting 
temperature (~80 °C)  than the oligo(ε-caprolactone)diol segments (~40 °C).  Using the 
lower melting point as the transition temperature (Ttrans = 40 °C), high strain fixity rates and 
strain recovery rates were demonstrated (Rf = 98 – 99.5 %; Rr = 98 – 99 % after three cycles 
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at ε = 200 %). The degradation rates displayed predictable linear kinetics that were changed 
using different ratios of oligo(ε-caprolactone)diol and oligo(p-dioxanone)diol. 
HO
OH
+ O
O
O
O
O
O
n
O
O
H
O
n
O
HO
OH
O
O
+
2 2
+
80 °C
Thermoplastic SMP
OCN
NCO
H
 
Scheme 6.  Thermoplastic SMP prepared by Langer et al.  
 
1.3.2 Thermoset SMPs   
Langer provided an excellent system that avoided the general drawbacks of 
thermoplastic SMPs; however, by chemically crosslinking SMPs, chain slipping and 
disentanglements are completely avoided.  A common method for synthesizing biomedical 
thermoset SMPs is by crosslinking macrodiols.1 Relative to the thermoplastic systems, the 
covalent crosslinks allow the shape-memory recovery of these materials to be independent of 
the packaging process.  Correspondingly, thermoset systems are generally more suitable for 
use as biomedical SMPs.  
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The first account of degradable thermoset biomedical SMPs was the preparation of 
oligo(ε-caprolactone) prepolymers that were photocured using methacryloyl chloride 
endcappers (Scheme 7).40  These semicrystalline SMPs (Tm = 41 – 51 °C); possessed 
excellent recovery properties (Rr > 99 %); and they did not exhibit cyclic hardening. 
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Scheme 7.  Thermoset SMP prepared by Lendlein et al.40  
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Lendlein also synthesized amorphous SMPs based on oligo[(L-lactide)-ran-glycolide] 
prepolymers with Tg = 55 °C; εmax = 195 % at 80 °C; Rf > 96 %; and almost quantitative Rr 
values (Scheme 8).41 Because of their morphology, there was interest in these materials as 
rapidly degrading implants.  Although no degradation was observed in 5 weeks under 
physiological conditions (pH = 7 and 37 °C), these systems exhibited 83 % mass loss after 5 
days at pH=7 and 70 °C. 
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O
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Scheme 8.  Thermoset SMP prepared by Lendlein et al.41 
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Similar amorphous systems were synthesized by crosslinking star oligo[(rac-lactide)-
co-glycolide] soft segments with 2,2,4-trimethylhexanediisocyanate (Ttrans = 36 °C - 59 °C; 
Scheme 9).42 The degradation profiles of these systems displayed an induction period of 
approximately 60 d followed by rapid mass loss in pH 7.0 aqueous phosphate buffer at 37 
°C. 
O
O
O
O
O
O
O
O
+
Dibutyltin Oxide
130 °C
129 h
H2CR
OH
OH
HO
+
R = OH and H
Three- and Four-armed Prepolymers
OCN
NCO
Thermoplastic SMP
 
Scheme 9.  Thermoset SMP prepared by Lendlein et al.14 
 
1.4 Limitations of Current Biomedical SMPs 
Currently, there are several limitations to biomedical SMPs.  Thermoplastic 
polyurethanes often exhibit fatigue at after several shape-memory cycles and their recovery is 
dependent on their packaging process.  Semicrystalline thermoplastic SMPs with multiple 
melting points do not exhibit cyclic hardening and possess good shape-memory properties (Rf 
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= 98 – 99.5 %; Rr = 98 – 99 %).3 However, semicrystalline materials often exhibit drawbacks 
such as low resiliency, swelling, and deformation upon degradation.  Furthermore, 
semicrystalline implants often possess non-linear biodegradation profiles due to the 
autocatalysis of acidic by-products trapped in the core of the devices.  This can lead to an 
unpredictable burst of acidic residues from the materials.43 Although they generally exhibit 
superior shape-memory properties, current thermoset biomedical SMPs are either 
semicrystalline40 or degrade slowly at physiological conditions.41,42  
Moreover, SMPs are currently designed for applications such as self-deployable 
stents or self-tightening sutures because they undergo delocalized changes in shape.  For 
example, entire devices are packaged, inserted, and then fully recovered in vivo (Figure 1.3; 
top).  There have no been reports of SMPs that are able to undergo localized shape changes, 
where changes are confined to only one part of the device, such as the surface (Figure 1.3; 
bottom).  Systems that undergo localized changes in shapes could be used for applications 
that are not currently available for SMPs, such as tissue engineering scaffolds or drug 
delivery vehicles.44,45  
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              Permanent Shape     Temporary Shape                   Permanent Shape 
 
Packaging        Recovery 
                                     
Figure 1.3  Representation of delocalized (top) and localized (bottom) shape changes 
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The previous sections described the current state of biomedical SMPs, their 
properties, and their ability to change shape in vivo.  Although several SMPs have 
demonstrated good shape-memory properties, there are still areas that need to be addressed, 
such as degradation rates, elasticity, and the possibility of delocalized shape changes.  The 
following chapters describe in detail efforts to produce materials that are: 
1) amorphous  
2) rapidly degrading 
3) highly elastic 
4) mechanically robust 
5) thermally-responsive 
6) suitable as shape-memory devices  
7) able to undergo localized changes in shape 
8) biocompatible 
1.5 Dissertation Organization 
 This dissertation is organized into five parts.  Chapter I is a general discussion on 
shape-memory materials and their biomedical applications.  Chapter II discusses the 
synthesis of novel amorphous prepolymers that were incorporated in thermoplastic 
polyurethane elastomers.  Chapter III discusses a class of thermoset polyurethanes based on 
poly(1,4-cyclohexanedimethanol 1,4-cyclohexanedicarboxylate) (PCCD) prepolymers that 
exhibited a range of thermal properties and showed potential as SMPs.  Chapter IV describes 
a novel process by which microscopic and nanoscopic shape-memory features may be 
imprinted on the surface of shape-memory materials for the design of new biomedical 
devices and applications.  Chapter V discusses continuing experiments and future research 
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directions.  Supplemental data for Chapters II through IV is presented in the appendices.  
Chapter II has been published in Macromolecules145 and the material in Chapters III and IV 
will be submitted for publication.  The material discussed in Chapter IV will also be filed for 
a patent application. 
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2.1 Introduction 
 
 Polyurethane elastomers have been used in numerous biomedical applications over 
the past few decades.1 Their broad range of mechanical properties enables them to be used as 
catheters,1-9 heart valves,1,10-14 bladders,1,15 tubing,1,15 blood filters,1,16-20 and wound 
dressings.1,21-24  The vast majority of biomedical polyurethane elastomers contain 
poly(tetramethyleneoxide) (PTMO) as the soft segment, which makes these materials 
biocompatible, elastic, and hydrophilic.  However, PTMO-based polyurethane elastomers are 
not biodegradable, a property that can be achieved when a biodegradable polymer, such as a 
polyester, is used as the soft segment.  Some of the more common polyesters used as soft 
segments in biomedical polyurethane elastomers are poly(butylene adipate), poly(ethylene 
adipate), and poly(caprolactone),1 which are all semicrystalline.  Using semicrystalline 
prepolymers often results in semicrystalline poly(ester urethane)s (PEUs), as the thermal 
properties of the soft segment often dictate the overall morphology of the PEU.  For example, 
Södergård et al. synthesized both semicrystalline PEUs (Tm = 125 – 138 °C) and amorphous 
PEUs by using a semicrysalline soft segment and an amorphous soft segment, respectively.25 
Although semicrystalline polymers possess many useful properties, they also exhibit 
drawbacks such as hydrophobicity, low resiliency, and swelling and deformation upon 
degradation.  Semicrystalline materials also have lower diffusion constants, which slow the 
degradation rate.  Furthermore, semicrystalline materials are not transparent, which is a 
requirement for applications such as ocular tissue replacements.26-29 By using an amorphous 
polyester precursor, a transparent PEU that is more hydrophilic and resilient can be prepared.  
Moreover, a PEU containing an amorphous soft segment will also have a faster more linear 
degradation profile. 
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There are some examples of amorphous thermoplastic PEUs reported in the literature.  
Seppälä et al. synthesized amorphous soft segments of lactic acid30-32 and comonomers33-34 
for PEUs and reported the biodegradation,35-37 the effect of fillers,38 and the rheological 
properties39 of these amorphous materials.  These PEUs have an extremely wide range of 
mechanical and thermal properties, yet they possess unpredictable, non-linear biodegradation 
profile.  Poly(lactic acid)-based materials often possess non-linear biodegradation profiles 
due to the autocatalysis of acidic by-products trapped in the core of the devices.  This can 
lead to an unpredictable burst of acidic residues from the materials.40 Prasath et al. prepared 
amorphous calcium-containing PEUs by reacting 2,4-tolylene diisocyanate with a mixture of 
the calcium salt of mono(hydroxybutyl)phthalate and hydroxyl-terminated poly(1,4-butylene 
glutarate).41  Although the modulus can be tuned very easily by varying the ionic content, the 
materials were not elastomeric.  Synthetic elastic materials are useful as implants because 
they resemble tissues similar to elastin, for which Winlove et al. reported as having a 
breaking strain of 200%.42 Marcos-Fernández et al. synthesized several amorphous poly(ester 
urethane urea)s with poly(caprolactone) as the soft segment and amino acid derivatives as the 
chain extenders.43  These materials were durable and elastic, but they were synthesized using 
heterogeneous chain extension – an unnecessary synthetic step in preparing useful poly(ester 
urethane)s.  Chain extension, whether heterogeneous or homogeneous, can be avoided 
altogether in synthesizing durable polyurethane elastomers, as Yilgor et al. recently 
proved.44,45  Therefore, a more facile, one-step method that excludes the use of chain 
extenders can be employed to synthesize durable poly(ester urethane)s.  Overall, the 
literature provides several amorphous poly(ester urethane)s that possess some beneficial 
characteristics for use as biodegradable materials in biomedical applications.  However, they 
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display at least one of the following features: 1) a non-linear biodegradation profile 2) low 
elasticity or 3) unnecessary chain extension.  Materials that possess the inherent attributes of 
PEUs, such as biocompatibility and biodegradability, along with hydrophilicity, more 
predictable biodegradation profiles, high elasticity, and facile synthetic procedures are very 
promising. 
Recently, we reported the preparation of completely amorphous, degradable, 
elastomeric poly(ester ether)s.46 The ether linkages ensured that the thermoset materials were 
hydrophilic and possessed very low glass transition temperatures, while the ester linkages 
ensured that the materials were degradable.  Because of the high degree of hydrophilicity, 
these materials rapidly degraded and displayed linear degradation profiles.  We have also 
reported the preparation of amorphous polyesters which were comprised of unsaturated 
cyclic moieties synthesized using Diels-Alder chemistry.47 These monomers were designed 
to easily change the hydrophilicity/hydrophobicity of the resulting polyester as well as to 
incorporate different functional groups.  The cyclic monomers ensured that the polyesters 
were amorphous.   
Herein, we describe the synthesis as well as the thermal and mechanical properties, 
degradation rates, surface properties, hydrophilicity, and cytotoxicity of several poly(ester 
urethane)s based on novel oligomeric diols (Scheme 1).  The poly(ester urethane)s and their 
corresponding prepolymers can be divided into two categories: those based on poly(ester 
ether) soft segments (P1 – P4; PEU1A – 1C, PEU2 – PEU4) and those that contain soft 
segments bearing cyclic structures synthesized using Diels-Alder chemistry (P5 – P7; PEU5 
– PEU7).   First, incorporating such hydrophilic and amorphous soft segments in the PEUs 
induced a much more predictable and faster rate of degradation than previously made 
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poly(ester urethane)s.  Second, using 4,4’-methylenebis(phenylisocyanate) as the 
monodisperse hard segment gave the PEUs high elastic properties.  Finally, these materials 
were synthesized using a simple one-step polymerization method, excluding the use of any 
chain extension. 
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2.2 Experimental Section 
2.2.1 Materials 
All reagents were purchased from Aldrich and used as received unless otherwise 
noted.  Toluene and N,N-dimethylacetamide (DMAc) were dried over calcium hydride, 
distilled before use, and stored on 4 Å molecular sieves.  Diethylene glycol was ≥ 99.0% 
pure and tetraethylene glycol was ≥ 99.5% pure.  Trans-β-hydromuconic acid (HMA) was 
purchased from TCI and recrystallized from water prior to use.  1,8-Octanediol (OD) was 
recrystallized from tetrahydrofuran.  A film of poly(caprolactone) was formed thermally for 
contact angle measurements.  1,4-Butanediol (BD) was vacuum distilled and stored on 4 Å 
molecular sieves.  4,5-Dimethylcyclohex-4-ene cis-1,2-dicarboxylic anhydride was 
synthesized according to the literature.47   
2.2.2 Characterization 
1H and 13C NMR spectra were acquired in deuterated chloroform on a Bruker 400 
AVANCE.  Polymer molecular weights were determined by gel permeation chromatography 
using a Waters GPC system with a Wyatt Optilab DSP interferometric refractometer as the 
detector.  Molecular weights were calculated using a calibration plot constructed from 
polystyrene standards.  The measurements were taken at 35 °C with tetrahydrofuran or at 50 
°C with N,N-dimethylformamide (0.05M LiBr) as the mobile phase on three columns 
(Waters Styragel HR5, HR4, and HR2).  Thermogravimetric analysis was performed on a 
PerkinElmer Pyris 1 TGA with a heating rate of 10 °C/min in a N2 atmosphere.  Glass 
transition temperatures were measured with a Seiko 220C differential scanning calorimeter, 
using a heating rate of 10 °C/min and a cooling rate of 10 °C/min in a N2 atmosphere.  Glass 
transitions were determined at the inflection point of the endotherm.  FTIR spectra were 
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acquired on a PerkinElmer Spectrum BX.  Elemental analysis was performed by Atlantic 
Microlab, Inc in Norcross, GA.  Contact Angle measurements were performed using a CAM 
200 Optical Angle Meter.  Five frames were captured at a frame interval of 300 seconds.  X-
Ray Photoelectron Spectroscopy data were taken using a Riber LAS-3000 with MgKα 
excitation (1254eV).  Energy calibration was established by referencing to adventitious 
Carbon (C1s line at 284.5eV binding energy).  The takeoff angle was ~75 ° from surface, and 
the x-ray incidence angle was ~20 ° and the x-ray source to analyzer ~55 °.  The base 
pressure in the analysis chamber was in the 10-10 torr range. 
Mechanical analysis was conducted on an Instron 5566 at a crosshead speed of 10 
mm/min at 25 °C.  The Young’s modulus (G) was calculated using the initial linear portion 
of the stress/strain curve (0 – 5 % strain).  Each measurement was performed on three 
separate samples.  The value was reported as the average of the three measurements.  
Dynamic mechanical analysis was performed using a PerkinElmer Pyris Diamond DMA.  
The measurements were taken with the tension mode with a frequency of 1 hertz from –100 
°C to 100 °C.  The glass transition temperatures were recorded as the maximum of the loss 
modulus.      
Elastomer films (0.15 g) were placed in 0.01 M pH 7.4 phosphate buffer saline 
solutions at 37 °C.  The films were removed from the buffer solution at the prescribed 
intervals, and dried under vacuum for 24 h before their mass was measured.  Each 
measurement was performed on three separate samples.  All error bars represent a 50 % 
confidence interval.  Mass loss (ML) was calculated according to the following equation, 
100×−=
i
ti
m
mmML  
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where mi and mt represent the initial mass and mass at time t.  Kinetic analyses of 
degradation were calculated according to zero-order kinetics. 
Elastomer films (0.15 g) were placed in 0.01 M pH 7.4 phosphate buffer saline 
solutions at 37 °C.  At the prescribed intervals, the swollen network was removed from the 
buffer solution, blotted dry, and the mass was recorded.  Each measurement was performed 
on three separate samples.  The water uptake (WU) was calculated according to the following 
equation, 
100×−=
d
ds
m
mmWU  
where ms and md represent the swollen and dry mass, respectively.  The value was reported 
as the average of three measurements.  All error bars represent a 50 % confidence interval. 
Minimum Essential Medium (MEM) elution tests were performed according to the 
ISO 10993-5 standard by Micromed Laboratories in Petaluma, CA.  Samples were extracted 
for 24 h at 37 °C and pH = 7.4 in minimal essential medium.  Extracts were placed on cell 
monolayers for 48 h at 37 °C and pH = 7.4.  L929 mouse fibroblast cells from the ATCC cell 
line were used.  At the conclusion of 48 h, the cells were examined and cytotoxicity was 
scored on a 0 to 4 scale, 0 being the least cytotoxic.  Cell growth and incubation were 
performed by the University of North Carolina Comprehensive Cancer Center Tissure 
Culture Facility.  Samples were either autoclaved or chemically treated and then separately 
incubated in the presence of rabbit endothelial vascular cells (REVC) for one week.  Imaging 
was taken with a Zeiss Axiovert 200 Inverted Microscope. 
2.2.3 Polyester Syntheses 
Adipic acid/HMA Polymerizations.  A 25-mL round bottom was charged with the 
acid and a stoichiometric excess of diol, targeting molecular weights of 5,000 g/mol.  The 
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contents of the flask were then placed under an argon atmosphere.  The mixture was stirred at 
130 °C using magnetic stirring, until a homogeneous melt was formed.  Stannous 2-
ethylhexanoate (1.0 mol %) was added to the melt.  The mixture was stirred for 1 h and the 
pressure was reduced to 20 mmHg for 23 h, for a total time of 24 h.  The polymerization was 
terminated by precipitating the polymer in cold diethyl ether (–78 °C).  Reactions were 
performed on a 10 – 25 g scale. 
Poly(diethylene glycol hydromuconate).  1H NMR: δ (ppm) = 5.67 (m, 2H), 4.21 (t, 
4H, J = 4.8 Hz), 3.71 (t, –CH2CH2OH end group, J = 4.3 Hz), 3.67 (t, 4H, J = 4.8 Hz), 3.57 
(t, –CH2CH2OH end group, J = 4.3 Hz), 3.10 (dd, 4H, J = 1.6, 3.8 Hz).  13C NMR: δ (ppm) = 
171.36 (CO2), 125.81 (–CH2CH=CHCH2–), 68.90 (–CO2CH2CH2O–), 63.60 (–
CO2CH2CH2O–), 37.53 (–CO2CH2CH=CHCH2–).  Anal. Calcd for C124H178O63: C, 55.65; H, 
6.66; O, 37.7.  Found: C, 55.31; H, 6.70; O, 38.00. 
Poly(tetraethylene glycol hydromuconate).  1H NMR: δ (ppm) = 5.66 (m, 2H), 4.21 (t, 
4H, J = 4.9 Hz), 3.67 (t, –CH2CH2OH end group, J = 4.9 Hz), 3.63 (s, 12H), 3.58 (t, –
CH2CH2OH end group, J = 4.8 Hz), 3.09 (dd, 4H, J = 1.5, 3.9 Hz).  13C NMR: δ (ppm) = 
171.42 (CO2), 125.82 (–CH2CH=CHCH2–), 70.47 (–CO2CH2CH2OCH2CH2–), 68.95 (–
CO2CH2CH2O–), 63.71 (–OCH2CH2OH end group), 37.56 (–CO2CH2CH=CHCH2–).   Anal. 
Calcd for C92H150O47: C, 55.03; H, 7.48; O, 37.49.  Found: C, 54.83; H, 7.53; O, 37.95. 
Poly(diethylene glycol adipate).  1H NMR: δ (ppm) = 4.20 (t, 4H, J = 4.8 Hz), 3.71 (t, 
–CH2CH2OH end group, J = 4.3 Hz), 3.66 (t, 4H, J = 4.7 Hz), 3.57 (t, –CH2OH end group, J 
= 4.3 Hz), 2.34 (t, 4H, J = 5.8 Hz), 1.64 (m, 2H).  13C NMR: δ (ppm) = 173.12 (CO2), 68.97 
(–CO2CH2CH2O–), 63.25 (–CO2CH2CH2O–), 33.64 (–CO2CH2CH2CH2–), 24.17 (–
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CO2CH2CH2CH2–).  Anal. Calcd for C134H218O68: C, 55.18; H, 7.48; O, 37.34.  Found: C, 
54.52; H, 7.56; O, 37.04. 
Poly(tetraethylene glycol adipate).  1H NMR: δ (ppm) = 4.16 (t, 4H, J = 4.9 Hz), 3.63 
(t, –CH2CH2OH end group, J = 4.8 Hz), 3.59 (s, 12H), 3.54 (t, –CH2CH2OH end group, J = 
4.8 Hz), 2.29 (t, 4H, J = 5.7 Hz), 1.60 (m, 4H).  13C NMR: δ (ppm) = 173.06 (CO2), 72.32 (–
CH2CH2OH end group), 70.34 (–OCH2CH2O–), 68.95 (–OCH2CH2CO2–), 63.26 (–
OCH2CH2CO2–), 61.49 (–CH2CH2OH end group), 33.55 (–CO2CH2CH2CH2–), 24.08 (–
CO2CH2CH2CH2–).  Anal. Calcd for C78H138O40: C, 54.61; H, 8.05; O, 37.34.  Found: C, 
54.09; H, 8.10; O, 37.93. 
 4,5-Dimethylcyclohex-4-ene cis-1,2-dicarboxylic anhydride Polymerizations.  A 25-
mL round bottom was charged with the anhydride and a stoichiometric excess of diol, 
targeting molecular weights of 5,000 g/mol.  The contents of the flask were then placed 
under an argon atmosphere.  The mixture was stirred at 160 °C using magnetic stirring, until 
a homogeneous melt was formed.  Stannous 2-ethylhexanoate (1.0 mol %) was added to the 
melt.  The mixture was stirred for 1 h and the pressure was reduced to 20 mmHg.  The 
reaction was allowed to proceed at 20 mmHg for 23 h, for a total time of 24 h.  The 
polymerization was terminated by precipitating the polymer in cold diethyl ether (–78 °C).  
Reactions were performed on a 10 – 25 g scale. 
Poly(1,8-octanediol 4,5-dimethylcyclohex-4-ene cis-1,2-dicarboxylate).
  
1H NMR: δ 
(ppm) = 4.05 (m, 4H), 3.62 (t, –CH2CH2OH end group, J = 3.62 Hz), 2.97 (t, 2H, J = 5.3 
Hz), 2.42 (dd, 2H, J = 5.0, 16.0 Hz), 2.30 (dd, 2H, J = 4.0, 16.0 Hz), 1.60 (s, 6H), 1.29 (s, 
10H).  13C NMR: δ (ppm) = 173.39 (CO2), 123.87 (–CH2C(CH3)=C(CH3)CH2), 64.50 (–
CH2CH2CH2CO2–), 62.87 (–CH2CH2CH2OH end group), 40.41 (–CO2CHCHCO2–), 32.68 (–
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CH2CH2CH2OH end group), 31.87 (–CH2C(CH3)=C(CH3)CH2–), 29.12 (–
CO2CH2CH2CH2CH2–), 28.50 (–CO2CH2CH2CH2–), 25.80 (–CO2CH2CH2CH2), 18.87 (–
C(CH3)=C(CH3)–).  Anal. Calcd for C152H242O34: C, 69.89; H, 9.35; O, 20.84.  Found: C, 
69.45; H, 9.36; O, 21.16. 
Poly(diethylene glycol 4,5-dimethylcyclohex-4-ene cis-1,2-dicarboxylate).  1H NMR: 
δ (ppm) = 4.21 (m, 4H), 3.71 (t, –CH2CH2OH end group, J = 3.6 Hz), 3.64 (m, 4H), 3.56 (t, –
CH2CH2OH end group, J = 4.6 Hz), 3.01 (t, 2H, J = 5.1 Hz), 2.44 (dd, 2H, J = 4.7, 15.7 Hz), 
2.24 (d, 2H, J = 15.7 Hz), 1.60 (s, 6H).  13C NMR: δ (ppm) = 173.19 (CO2), 123.80 (–
CH2C(CH3)=C(CH3)CH2–), 68.89 (–CO2CH2CH2O–), 63.45 (–CO2CH2CH2O–), 40.27 (–
CO2CHCHCO2–), 31.70 (–CH2C(CH3)=C(CH3)CH2–), 18.87 (–CH2C(CH3)=C(CH3)CH2–).  
Anal. Calcd for C130H190O48: C, 61.95; H, 7.54; O, 30.5.  Found: C, 61.62; H, 7.77; O, 30.8.   
Poly(tetraethylene glycol 4,5-dimethylcyclohex-4-ene cis-1,2-dicarboxylate).  1H 
NMR: δ (ppm) = 4.20 (m, 4H), 3.69 (t, –CH2CH2OH end group, J = 4.1 Hz), 3.62 (m, 12H), 
3.00 (m, 2H), 2.42 (dd, 2H, J = 4.7, 15.9 Hz), 2.22 (dd, 2H, J = 4.0, 15.6 Hz), 1.59 (s, 6H).  
13C NMR: δ (ppm) = 173.17 (CO2), 123.76 (–CH2C(CH3)=C(CH3)CH2–), 70.50 (–
CO2CH2CH2OCH2–), 68.99 (–CO2CH2CH2O–), 63.52 (–CH2CH2OH), 40.23 (–
CO2CHCHCO2–), 31.67 (–CH2C(CH3)=C(CH3)CH2–), 18.83 (–C(CH3)=C(CH3)–).  Anal. 
Calcd for C100H162O41: C, 59.46; H, 8.03; O, 32.5.  Found: C, 58.95, H, 8.16; O, 32.89. 
Poly(ester urethane) syntheses.  A typical poly(ester urethane) synthesis with 20  or 
10 wt % hard segment is as follows.  All glassware was flame-dried.  A solution of the 
polyester in 10 mL DMAc was prepared and cannulated to an addition funnel connected to a 
100 mL 3-necked round bottom flask equipped with a mechanical stirrer.  The appropriate 
amount of 4,4’-methylenebis(phenylisocyanate) (MDI) (20 or 10 wt % of the prepolymer) 
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was weighed and added to the 100-mL flask.  DMAc (5 mL) was added to the flask.  The 
prepolymer solution was added dropwise to the reaction flask with constant stirring.  The 
reaction was heated at 80 °C for 2 h.  The reaction was precipitated at 0 °C water and dried at 
70 °C for 2 d.  Films were solution cast from DMAc and dried at 50 °C for 1 d and then at 80 
°C in a vacuum oven for 4 d. 
 Poly(ester urethane) with 40 wt % hard segment polymerization.  The reaction which 
utilized 40 wt % MDI required chain extender and was monitored by FTIR (disappearance of 
strong isocyanate signal at 2270 cm-1).  This reaction was terminated by 1-butanol near the 
completion of the reaction.  No gelation occurred during any of the poly(ester urethane) 
syntheses. 
2.3 Results and Discussion 
2.3.1 Polyester Prepolymers 
Seven polyester prepolymers were prepared for this study (Scheme 1).  The first and 
second polymers were derived from trans-β-hydromuconic acid (HMA) and a calculated 
excess of diethylene glycol or tetraethylene glycol (P1 and P2, respectively).  The third and 
fourth prepolymers were derived from adipic acid (AA) and a calculated excess of diethylene 
glycol or tetraethylene glycol (P3 and P4, respectively).  The final three prepolymers were 
derived from polymerizing 4,5-dimethylcyclohex-4-ene cis-1,2-dicarboxylic anhydride with 
a stoichiometric excess of 1,8-octanediol (P5) , diethylene  glycol (P6), or tetraethylene 
glycol (P7) (Scheme 1).  The molecular weight, polydispersity, and thermal data for these 
prepolymers are shown in Table 2.1. 
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Table 2.1  Polyester prepolymers synthesized at 130 °C (P1-P4) or 160 °C (P5-P7), 20 
mmHg, and 24 h 
 
Sample ‹Mn› × 10-3 (g/mol)a ‹Mn› × 10-3 (g/mol)b PDIa Tg (°C)d Yield (%) 
P1 3.37 2.67 2.05 –29.2 80.4 
P2 3.41 2.00 1.90 –39.3 85.2 
P3 3.23 2.91 2.11 –47.2 80.2 
P4 2.53 1.71 1.87 –50.0 79.5 
P5 2.76 2.61 1.96 –23.9 81.6 
P6 1.51 2.52 1.88 –5.0 80.5 
P7 1.96 e 1.69 –26.4 88.3 
aBased on GPC analysis.  bBased on NMR analysis.  cBased on TGA analysis.  dBased on 
DSC analysis.  eEndgroup signals not discernable in 1H NMR spectrum. 
 
The molecular weights of P1-P7 based on gel permeation chromatography were 
within a 2 × 103 g/mol window, ranging from 1.5 × 103 g/mol to 3.4 × 103 g/mol.  The 
molecular weights were all lower than the target molecular weight (5.0 × 103 g/mol) due to 
the loss of monomers under reduced pressure.  These molecular weights are in a range that is 
well-suited for soft segments in thermoplastic polyurethanes,1 and the polydispersities were 
close to 2.0 (1.7 – 2.1) as expected by step growth kinetics.  All NMR spectra indicated that 
these prepolymers were terminated only by hydroxyl groups, and these endgroup signals 
were used to calculate the ‹Mn›.  Overall there was a relatively lower estimation of ‹Mn› by 
NMR analysis when compared to the GPC-based ‹Mn› calculations for all of the samples 
except P6.  In most of the 1H NMR spectra (Supporting Information), endgroup signals 
partially overlapped with signals that corresponded to hydrogens in the polymer backbone or 
residual monomer, which effectively lowered the ‹Mn› calculations.  Endgroup signals were 
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clearly discernable in the 1H NMR spectrum of P6, however, which resulted in a higher 
estimation of ‹Mn› by NMR analysis.  The 1H NMR spectrum of P5 displayed the most 
discernable endgroup signals (δ = 3.62 ppm), which are also present in the 13C NMR 
spectrum (δ = 62.9 and 32.7 ppm) (Figure 2.1).  Hydroxyl endgroup signals for TEG-based 
polymers were either absent or difficult to visualize using 1H NMR analyses, yet the signals 
were quite evident in the 13C NMR spectra (δ = 63.5 ppm).  The endgroup signals for the 
DEG-based prepolymers, although present in the 1H NMR spectra, were not present in the 
13C NMR spectra.  There was no indication of any carboxyl-terminated prepolymers using 
NMR analyses.  Infrared spectroscopy was also used to determine that the polyester 
prepolymers had only hydroxyl-terminated endgroups (Supporting Information).  A broad 
peak at 3500 cm-1 and a sharp peak at 1735 cm-1 correspond to hydroxyl groups and (ester) 
carbonyl groups, respectively.  Stretching absorptions corresponding to carboxyl groups 
(3300 and 1700 cm1) were not present in the FTIR spectra.  The combination of 1H NMR, 
13C NMR, GPC, and FTIR analyses indicated that low molecular weight hydroxyl-terminated 
polyester prepolymers were successfully synthesized.  
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Figure 2.1  1H NMR (top) and 13C NMR (bottom) spectra of P5 (4,5-dimethylcyclohex-4-
ene cis-1,2-dicarboxylic anhydride-1,8-octanediol prepolymer) 
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All glass transition temperatures were significantly below 0 °C, with the AA-based 
polymers (P3 and P4) having the lowest values (–47.2 and –50.0 °C).  As expected, each 
DEG-based polymer had a higher glass transition temperature than its corresponding TEG-
based polymer [Tg (P1) > Tg (P2); Tg (P3) > Tg (P4); and Tg (P6) > Tg (P7)].  While the Tg of 
P6 (– 5 °C) was higher than expected, it was also reproducible.  Seppälä et al. demonstrated 
that glass transition temperatures of amorphous PEUs are dictated by the thermal transitions 
of their prepolymers.33 By using 1,6-hexamethylene diisocyanate as the hard segment, a 
number of poly(ester urethane)s were synthesized that possessed a relatively narrow range of 
glass transition temperatures higher (5 – 15 °C) than their prepolymers.  In this work, every 
prepolymer possessed a relatively low glass transition temperature (Tg = –50.0 – –5.0 °C).  
This ensures that the resulting poly(ester urethane)s have glass transition temperatures below 
body temperature (37 °C), meaning that the PEUs are elastomeric at physiological 
conditions. 
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Scheme 2.  General structure of poly(ester urethane)s PEU1 – PEU7 
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2.3.2 Poly(ester urethane) Synthesis 
  A one-step method where an aromatic diisocyanate, 4,4’-
methylenebis(phenylisocyanate) (MDI), reacted with the hydroxyl-terminated polyester 
prepolymer was utilized for our study.  PEU1A-1C and PEU2-PEU7 were successfully 
synthesized by this method.  Prepolymers P1–P7 were used to prepare poly(ester urethane)s 
PEU1B and PEU2-PEU7, which all contained 20 wt % hard segment.  The effect of the MDI 
was studied by varying its content (10, 20, and 40 wt %; PEU1A, PEU1B, and PEU1C 
respectively) for prepolymer P1.  Because FTIR showed no strong isocyanate signal (2270 
cm-1) after 2 h of reaction time for those reactions using 10 and 20 wt % MDI, no chain 
extenders were used.  A strong isocyanate peak was present, however, after 2 h of reaction 
time for PEU1C, the polyurethane which comprised 40 wt % hard segment.  Therefore, 1,4-
butanediol, a very common chain extender,1 was employed and the disappearance of the 
isocyanate peak was monitored using FTIR.  1-Butanol was used to terminate this reaction 
near its completion to avoid any gelation.  The thermal and mechanical properties of the 
poly(ester urethane)s are shown in Table 2.2. 
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Table 2.2  Thermal and mechanical data for poly(ester urethane)s synthesized at 80 °C in 
DMAc for 2 h 
 
Sample ‹Mn›a × 10-4 g/mol PDIa Tgb (°C) Tgc (°C) Gd (MPa) εmaxe (%) 
    
    
PEU1Af 2.7 1.5 –25.0 m m m 
PEU1Bg 6.1 1.9 –17.6 –23.0 3.44 2106p 
PEU1Ch 2.3 1.7 –16.0 –21.5 m m 
PEU2k 4.3 1.5 –28.2 –43.8 4.68 133 
PEU3 6.4 1.4 –34.6 –52.1 4.41 375 
PEU4 2.9 1.4 –46.2 m m m 
PEU5 3.4 1.5 –0.2 –9.2 0.86 n 
PEU6 2.5 1.4 18.5 m 29.3 281 
PEU7 3.3 1.6 –8.0 –14.8 1.12 n 
 
aBased on GPC analysis.  bBased on DSC analysis.  cBased on DMA analysis.  dYoung’s 
modulus.  eUltimate strain.  f10 wt %; g20 wt %; and h40 wt % MDI.  kNumber denotes which 
prepolymer is used as soft segment (P2 is prepolymer for PEU2); PEU2-PEU7 contain 20 wt 
% MDI.  mCould not determine using DMA analysis or Instron analyis.  nMechanically 
failed.  p50 mm/min. 
 
2.3.2.1 Molecular Weight Analysis 
The molecular weights and polydispersity of these samples were measured using gel 
permeation chromatography with N,N-dimethylformamide as the mobile phase.  All PEUs 
were of high molecular weights, falling within a range of ‹Mn› = 2.3 – 6.4 × 104 g/mol.  A 
broad range of molecular weights for polyurethane elastomers is certainly not 
uncommon,33,48 and because they are all relatively high molecular weight and are above the 
critical molecular weight of entanglement, any differences in mechanical properties should 
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not be due to differences in molecular weight.  The polydispersity of each sample was lower 
than the theoretical value (PDI = 2.0).  This is most likely due to these polymers being highly 
soluble in DMAc, the solvent used in the polymerization conditions.  Upon precipitation, the 
lower molecular weight chains remained soluble in the good solvent, which resulted in lower 
PDI values. 
2.3.2.2 Thermal Analysis 
The one-step polyurethane synthetic method resulted in thermoplastic elastomers with 
a relatively large range of thermal and mechanical properties.  The glass transition 
temperatures of the PEUs correlated well with the thermal properties of their corresponding 
prepolymers and were ~15 °C higher than the glass transition temperatures of the 
corresponding prepolymers.  The glass transition temperatures for the PEUs ranged from –
46.2 – 18.5 °C.  PEU6 (4,5-dimethylcyclohex-4-ene cis-1,2-dicarboxylic anhydride-
diethylene glycol prepolymer) displayed the highest glass transition temperature in this study 
(Tg = 18.5 °C), which was anticipated as its prepolymer (P6) also possessed a relatively high 
glass transition temperature (–5.0 °C).  PEU4 (adipic acid-tetraethylene glycol prepolymer) 
possessed a relatively low glass transition temperature (–46.2 °C) as did the prepolymer P4 
(–50.0 °C).  All of the materials are in the rubbery phase at body temperature (37 °C).  Using 
the one-step polymerization method for prepolymers with glass transition temperatures 
greater than ~22 °C would result in glassy poly(ester urethane)s at physiological conditions.  
Consequently, this method has potential use for preparing amorphous shape-memory 
materials for biomedical applications, which require very specific thermal transitions.49-51 
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2.3.2.3 Mechanical Analysis 
All PEUs showed a distinct decrease in storage modulus near the glass transition 
temperature.  The storage moduli then formed a rubbery plateau in the 101 MPa range at 
temperatures above the glass transition as shown in Figure 2.2, which is the DMA data 
generated for PEU1B (HMA-diethylene glycol prepolymer/20 wt % hard segment).  The 
glass transition for PEU1B is clearly visible from the sharp decline in E’ and the peak in tan 
δ.  The glass transition temperatures were measured as the maximum value of the loss 
modulus (not shown), which is –23.0 °C for PEU1B. 
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Figure 2.2  Storage modulus (E’) and tan δ plotted versus temperature for PEU1B 
 
  Poly(ester urethane)s with high moduli at lower temperatures did not necessarily 
possess good mechanical properties at higher temperatures.  For example, PEU7 possessed 
the highest storage modulus at –100 °C of the measurable samples, but this material had the 
lowest modulus at 25 °C or 37 °C.  PEU1A (HMA-diethylene glycol prepolymer/10 wt % 
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hard segment) and PEU4 (adipic acid-tetraethylene glycol prepolymer) were too soft for 
DMA analysis, while PEU6 (4,5-dimethylcyclohex-4-ene cis-1,2-dicarboxylic anhydride-
diethylene glycol prepolymer) was too brittle for DMA analysis.  It seems that a PEU 
containing 20 wt % hard segment displayed optimum mechanical properties because PEU1B 
(20 wt %) had sufficient mechanical properties for DMA analysis but both PEU1A (10 wt %) 
and PEU1C (40 wt %) were unsuitable for DMA analysis.  The DMA analyses also 
supported the evidence that these materials are completely amorphous, as semicrystalline 
polyurethanes display changes in storage modulus and tan δ at higher temperatures.45 The 
DMA data for these poly(ester urethane)s showed no such transitions at higher temperatures. 
Instron analysis measured the mechanical properties using isothermal analysis.  The 
Young’s moduli of the measurable materials ranged from 0.86 MPa (PEU5) to 29.3 MPa 
(PEU6).  PEU1B has remarkable elasticity with a high ultimate strain (ε
 max = 2106 %).  This 
material did not break at a crosshead speed of either 10 mm/min or 30 mm/min and retained 
its original shape in a matter of seconds following those trials.  This material broke only after 
increasing the crosshead speed to 50 mm/min.  Both Seppälä33 and Hilborn52 synthesized 
amorphous poly(ester urethane)s with high elasticity (ε >1000%).  PEU2, PEU3, and PEU6 
had ultimate strains ranging from ε
 max = 133 – 281 %, which are similar to the ultimate strain 
of pure elastin (ε
 max = 200 %).42 PEU1A, PEU1C, and PEU4 were too soft for Instron 
analysis while PEU5 and PEU7 did not give a clean break under high strain.  A typical stress-
strain curve obtained by Instron analysis is shown for PEU3 (AA-diethylene glycol 
prepolymer/20 wt % hard segment) (Figure 2.3).  PEU3 had an average Young’s modulus of 
4.41 MPa and an ultimate elongation of 375%.  When compared to standard poly(ether 
urethane)s (PTMO soft segment, MDI hard segment; G = 18.1 MPa, ε
 max = 675 %)53, 
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PEU1B (ε
 max = 2106 %) had superior elasticity and PEU6 (G = 29.3 MPa) had a superior 
Young’s modulus.  Poly(ester urethane) samples PEU1B, PEU2, PEU3, and PEU6 had 
excellent mechanical properties and are promising for use in biomedical applications. 
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Figure 2.3  Tensile stress (MPa) plotted versus strain (%) for PEU3 
 
2.3.2.4 Surface and Bulk Characterization 
Thus far, we have shown a method that produces completely amorphous poly(ester 
urethane)s that are elastomeric at 37 °C and display excellent mechanical properties such as 
high elasticity or resiliency.  As these materials are designed as biodegradable devices, an 
understanding of their surface and bulk properties is important.  Previously, we have shown 
that the rates of degradation for poly(ester ether)s are affected by the materials’ 
hydrophilicity and water uptake.46  Here, we measured the contact angles formed by water 
droplets placed on the PEU surfaces over a 20 minute time period.  The contact angle 
measurements for the PEUs were compared with that of poly(caprolactone) (PCL) (Figure 
2.4).   
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Figure 2.4  Contact angles of all polymer samples and poly(caprolactone) versus time 
 
 For the purpose of clarity, the PEUs are divided into two groups: those that derive 
from poly(ester ether) prepolymers (PEU1B, PEU1C, PEU2, PEU3, and PEU4) and those 
that derive from the polyesters bearing cyclic moieties (PEU5, PEU6, and PEU7).  The 
contact angles differ as such: [PEU2 (most hydrophobic) > PEU1B > PEU3 > PEU1C > 
PEU4 (most hydrophilic)] and [PEU6 (most hydrophobic) > PEU5 > PEU7 (most 
hydrophilic)].  Most of these materials were hydrophobic, as they were in the same range as 
PCL (θ5min = 65 °).  All contact angles decrease as time increases due to the droplets 
spreading on the polymer surfaces.  To compare the surface properties with the bulk 
properties of these materials, water uptake data was recorded over a 3 day period (Supporting 
Information).  The water uptake data differ as such: [PEU2 (most water uptake after 3 d) > 
PEU1B ~ PEU3 > PEU1C > PEU4 (least water uptake after 3 d)] and [PEU7 (most water 
uptake after 3 d) > PEU5 > PEU6 (least water uptake after 3 d)].  These results certainly 
show that, for the poly(ester urethane)s containing poly(ester ether) soft segments, the 
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surface properties differ from the bulk properties.  The components for all of these materials 
include hydrophilic soft segments and hydrophobic aromatic hard segments,41 and the 
relative amounts of each may differ at the polymer surface and in the bulk when wet.  
Previous studies have shown that copolymers or polymer blends often exhibit the surface 
segregation phenomenon, a process in which lower energy constituents adsorb preferentially 
at the surface in order to lower the overall surface free energy.54-60 Other studies have 
confirmed that polyurethanes exhibit surface restructuring upon contact with water.61,62  
Although the contact angle measurements indicated unique surface properties, further 
experiments were required to determine whether any phenomenon was occurring during the 
contact angle measurements.  Contact angle measurements are rather qualitative and time-
dependent; therefore, x-ray photoelectron spectroscopy (XPS) analysis of the surface was 
obtained to further elucidate the surface properties of the materials discussed here.  Because 
there were no nitrogen atoms in the prepolymers, the nitrogen content of the samples shows 
the relative urethane concentrations (hydrophobic hard segments) at the surface of dry PEU 
films.  The XPS data revealed that the nitrogen content for PEU2 = 1%, PEU4 = 2%.  These 
data support that the materials derived from the poly(ester ether) prepolymers are in fact 
undergoing the surface segregation phenomenon during the contact angle measurements.  If 
this phenomenon was not present, PEU4 would have a higher contact angle than PEU2 
because the hard segment content in PEU4 is relatively more concentrated at the surface of a 
dry sample.  The class of poly(ester urethane)s which derive from prepolymers bearing cyclic 
moieties are slightly more complicated due to the relatively high Tg of PEU6.  Contact angle 
measurements are affected at temperatures near the glass transition temperature63, and the 
interfacial energy and glass transition temperature for polymer films are directly 
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proportional.64 Because of this, it is still not yet determined whether the second class of 
materials exhibit the surface segregation phenomenon as well as whether it is the soft 
segment cyclic moieties or the thermal properties that most affect the surface properties of 
PEU5, PEU6, and PEU7. 
2.3.2.5 Degradation Studies 
As these poly(ester urethane)s differ in terms of thermal properties, mechanical 
properties, and hydrophilicity, they degraded at different rates in an in vitro degradation 
study.  Samples were left in a phosphate buffer medium (pH = 7.4) at 37 °C for six weeks, 
and the medium was changed weekly.  Three PEUs (PEU1A, PEU2, and PEU4) degraded 
within that time period (Figure 2.5).   
Kinetic analysis was conducted using zero-order kinetics in addition to first-order 
kinetics because hydrolysis of polyesters have been explained using both methods.46,65  Both 
PEU1A and PEU2 degrade according to zero-order kinetics; however, PEU4 does not 
degrade according to either zero-order or first-order kinetics for the entire degradation study.  
The degradation profile of PEU4 exhibits a sharp increase in mass lost for the first week 
followed by a more linear increase for the remainder of the experiment.  The non-linear 
degradation profile of PEU4 can best be explained using the results from the contact angle 
studies, water uptake studies, and XPS studies.  These studies showed that these materials 
exhibited a surface segregation phenomenon, meaning that a material’s surface was quite 
different from its bulk in an aqueous environment.  The degradation profile indicates that the 
surface of PEU4 degraded at a faster rate than the bulk.  Gardella, Jr. et al. demonstrated how 
the surface degradation kinetics differ from that of the bulk for biodegradable polyesters.66 
During a material’s degradation time, an initial “induction” period is present that is 
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dominated by surface and interfacial reactions until the equilibration of water penetration and 
absorption leads to bulk degradation processes.  This “induction” period is present for all 
samples, thus the discrepancy in the profile of PEU4 during the first 7 d is more likely due to 
the low mechanical properties of the hydrophilic surface (4.5 % mass lost by simply washing 
a 0.15 g sample with H2O).  Because both zero-order or first-order rate laws do not apply for 
the entire span of the experiment for PEU4, zero-order rate laws were applied to each profile 
following the first week (0.31, 0.13, and 0.19 % mass lost/day for PEU1A, PEU2, and PEU4 
respectively).  The rate of PEU1A may be explained by its relatively lower content of 
hydrophobic hard segment.  The % mass lost for PEU2 and PEU4 was measured after 100 
days were 12.2 % and 29.9 % respectively, which correlate well with what the zero-order 
kinetic analyses predicted (13.3 % and 35.5%).  None of these materials displayed a ‘burst 
effect’, which is prevalent in many poly(ester urethane)s.33,37 PEU2 is an extremely 
promising material as it possesses good mechanical properties (E = 4.68 MPa, γmax = 133 %) 
and a linear degradation profile.  PEU1A, PEU2, and PEU4 are among the fastest degrading 
poly(ester urethane)s recorded to date.     
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Figure 2.5  Mass loss (%) plotted versus time (d) for PEU1A, PEU2, and PEU4 
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2.3.2.5 Cytotoxicity Studies 
Studies have shown that aromatic-based materials, if treated under harsh, basic 
conditions, can produce aromatic amines, which are highly toxic.  There has been 
contradictory evidence disputing whether or not this 1) happens in the human body and 2) if 
the amounts are at toxic levels.1 The alternative to this possibility is the use of an aliphatic 
isocyanate, as aliphatic amines are less detrimental in biological environments.  However, by 
using an aliphatic diisocyanate, there is loss in mechanical and thermal properties.  Our 
studies have shown that aliphatic diisocyanates are unsuitable for our one-step method of 
preparing amorphous poly(ester urethane) thermoplastic elastomers with high mechanical 
integrity. 
Because of the evidence indicating that aromatic-based polyurethanes are cytotoxic, 
the cytotoxicity characteristics of these materials were tested using two methods.  The first 
being a minimum essential medium elution test.  The materials were extracted with a 
minimum essential medium for 24 h and 48 h at physiological conditions.  The extracts were 
then placed on confluent monolayers of L-929 mouse fibroblast cells.  All poly(ester 
urethane)s scored 0, indicating no cytotoxic response, with the exception of PEU7.  PEU7 
was repeatedly characterized as severely cytotoxic even after rigorous drying or several 
extractions.  It is still not well understood as to why this particular sample was cytotoxic.  
There was no difference in the crosslink density of PEU7 when compared to the other 
materials in this study, as all reactions containing 20 wt % hard segment were carried out to 
completion.  Also, the molecular weight, mechanical properties, or structural features of this 
material give no further reasoning as to why this particular sample was cytotoxic.  Further 
testing is required to better explain this anomaly.   
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The second method was used only for samples PEU2, PEU3, and PEU7 and was 
designed to test how these materials responded under different sterilization methods.  PEU2 
and PEU7 were autoclaved; PEU3 was partitioned into two samples: one was chemically 
treated (ethanol) and the other was autoclaved.  They were then separately incubated in the 
presence of rabbit endothelial vascular cells (REVC) for 1 week.  PEU7 could not be tested 
because autoclaving proved too harsh of a sterilization method making this sample unsuitable 
for handling.  This was not surprising as PEU7 had a relatively low modulus, even at 37 °C 
(Table 2.2).  The autoclave-sterilized PEU2, autoclave-sterilized PEU3, and ethanol-
sterilized PEU3 are all non-toxic, as shown in Figure 2.6.  The figure clearly shows that 
autoclaving methods of sterilization are not detrimental to those samples with sufficient 
moduli.  There are no signs of either sterilization method inducing any cytotoxic response 
from the materials, as there was zero cell death.  This test demonstrated that two poly(ester 
urethane)s, PEU2 and PEU3, show no cytotoxicity, even after 1 week of incubation with the 
REVC cells.  These initial cytotoxicity tests indicate that these materials are promising for 
biomedical purposes; however, further testing is required for these materials to ascertain 
whether they are biocompatible. 
 
   
 
 
Figure 2.6  Autoclave-sterilized PEU2 (left); autoclave-sterilized PEU3 (middle); ethanol-
sterilized PEU3 (right); darker portions of image(s) are the polymer sample(s) 
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2.4 General Conclusions 
A one-step method has been used to prepare versatile degradable, amorphous 
poly(ester urethane) thermoplastic elastomers with novel soft segments without the use of a 
chain extender.  These materials show a wide range of mechanical properties, including 
highly elastic materials (εmax = 2106 %).  These materials displayed a surface segregation 
phenomenon when in contact with aqueous solutions.  Three poly(ester urethane)s, PEU1A, 
PEU2, and PEU4 showed appreciable degradation at 37 °C during the 6-week study and 
possessed relatively fast degradation rates.  Studies on PEU2 and PEU3 showed that different 
methods of sterilization do not induce cytotoxic behavior in these materials.  Current efforts 
are being made towards synthesizing amorphous degradable thermoplastic poly(ester 
urethane)s with shape-memory properties. 
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3.1 Introduction 
The thermoplastic polyurethane elastomers presented in Chapter II were promising 
for degradable in vivo applications, but their thermal properties were insufficient (Tg < 18 °C) 
for use as biomedical SMPs.  In order to prepare optimized SMPs, prepolymers with 
increased thermal properties were designed and tested as soft segments.  Herein we describe 
the synthesis and characterization of degradable thermoset SMPs with glass transition 
temperatures ranging from 54 – 140 °C that were based on photocurable poly(1,4-
cyclohexanedimethanol 1,4-cyclohexanedicarboxylate) (PCCD) prepolymers.  The synthesis 
and characterization of the PCCD prepolymers as well as the elastomers are discussed, and 
their potential as biomedical SMPs is demonstrated.  
3.2 Experimental Section 
3.2.1 Materials 
   All materials were purchased from Aldrich unless otherwise noted.  1,4-
Cyclohexanedimethanol (CDM; 99%) was a 17.2/82.8 molar ratio of cis/trans isomers, and 
1,4-cyclohexanedicarboxylic acid (CDC; 99%) was a 76.3/23.7 molar ratio of cis/trans 
isomers as measured by 1H NMR.  2,2-Diethoxyacetophenone (98%) was purchased from 
Acros Organics.  Methylene chloride was distilled before use and stored on 4 Å molecular 
sieves. 
3.2.2 Characterization 
1H and 13C NMR spectra were acquired in deuterated chloroform on a Bruker 400 
AVANCE.  Polymer molecular weights were determined by gel permeation chromatography 
(GPC) using a Waters GPC system with a Waters 2414 refractometer.  Molecular weights 
were calculated using a calibration plot constructed from polystyrene standards.  The 
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measurements were taken at 35 °C with tetrahydrofuran as the mobile phase on four columns 
(Waters Styragel HR5, HR4, HR2, and HR0.5).  Photochemical curing was accomplished 
using a UV oven chamber (ECL-500) that was purged with N2 for 10 min prior to irradiation.  
Thermogravimetric analysis was performed on a PerkinElmer Pyris 1 thermal gravimetric 
analyzer (TGA) with a heating rate of 10 °C/min in a N2 atmosphere.  Glass transition 
temperatures of the prepolymers were measured with a Seiko 220C differential scanning 
calorimeter (DSC), using a heating rate of 10 °C/min and a cooling rate of 10 °C/min in a N2 
atmosphere.  Glass transition temperatures were determined as the inflection point of the 
endotherm on the 2nd heating step.  FTIR spectra were acquired on a PerkinElmer Spectrum 
BX.  Mechanical analysis was conducted on an Instron 5566 at a crosshead speed at 10 
mm/min at 25 °C or with an Instron SFL 3119-506 Heatwave Temperature Controlled 
Chamber for measurements at higher temperatures.  The Young’s modulus (G) was 
calculated using the initial linear portion of the stress/strain curve (0 – 5% strain).  Dynamic 
mechanical analysis was performed using a PerkinElmer Pyris Diamond dynamic mechanical 
analyzer (DMA).  The measurements were taken using the tension mode with a frequency of 
1 Hz from –100 °C to 100 °C.   
Sol-Gel analysis was conducted by swelling a 0.25 g elastomer film in diethyl ether 
for 24 h at 25 °C followed by methylene chloride for 24 h at 25 °C.  After 24 h, the samples 
were weighed to calculate the change in weight from swelling according to the equation 
10024 ×−=
i
ih
m
mm
ζ  
where mi is the initial weight and m24h is the weight of the swollen polymer after 24 h.  After 
the solvent was completely removed, the percent soluble fraction (Qs) was determined 
according to the following equation 
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where mi and mf represent the initial and final mass, respectively.  The measurements were 
performed in triplicate.  Fully extracted films were prepared by drying the extracted films in 
a vacuum oven at 100 – 110 °C for several days, until a constant weight was achieved. 
Shape-Memory Characterization.  Samples were clamped in the Instron and heated 
using a thermal chamber.  The measurements were performed only after the temperature had 
reached equilibrium.  The packaging and reformation studies were performed by elongating 
the samples to σ = 200 % at T = Tg – 5 °C.  The samples were then allowed to cool to room 
temperature and measured in length.  Reformation was accomplished by submerging the 
samples in a water bath set to 64 °C, and complete reformation occurred after 6 s.  Strain 
fixity rates were calculated using the equation 
m
u
f
n
nR
σ
σ )()( =  
where σu(n) represents the strain in the stress-free state after having it packaged and σm is the 
maximum strain.  Strain recovery rates were calculated using the equation 
)1(
)()()(
−−
−
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n
nn
nR
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where σp(n) is the elongation of the sample at the beginning of the nth cycle.  All reported 
values were averages of at least three measurements. 
Minimum essential medium (MEM) elution tests were performed according to the 
ISO 10993-5 standard by Micromed Laboratories in Petaluma, CA.  Samples were extracted 
for 24 h at 37 °C and pH = 7.4 in minimal essential medium.  Extracts were placed on cell 
monolayers for 48 h at 37 °C and pH = 7.4.  L929 mouse fibroblast cells from the ATCC cell 
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line were used.  At the conclusion of 48 h, the cells were examined and cytotoxicity was 
scored on a 0 to 4 scale, 0 being the least cytotoxic. 
3.2.3 Prepolymer Synthesis   
Hydroxyl-endcapped prepolymers were synthesized according to the following 
procedure.  A 500-mL round bottom flask was charged with 1,4-cyclohexanedicarboxylic 
acid and a stoichiometric excess of 1,4-cyclohexanedimethanol.  The flask was purged with 
N2, and the contents were heated to 130 °C and stirred until a homogeneous melt formed.  
Stannous 2-ethylhexanoate (Sn(Oct)2; 1.0 mol%) was added to the melt.  The mixture stirred 
for 1 h, and the pressure was reduced to 20 mmHg.  The reaction was allowed to proceed at 
20 mmHg for 24 h, at which point the pressure was reduced to 0.1 mmHg.  The reaction was 
allowed to proceed for 24 h.  The resulting prepolymer was stored at 100 °C at 0.1 mmHg.  
Reactions were performed on a 25 – 50 g scale. 
Poly(1,4-cyclohexanedimethanol 1,4-cyclohexanedicarboxylate) (PCCD).  1H NMR: 
δ (ppm) = 3.97 (d, 4H, J = 6.9 Hz), 3.88 (d, 4H, J = 6.3 Hz), 3.52 (d, cis–CH2OH endgroups, 
J = 7.0 Hz), 3.40 (d, trans–CH2OH endgroups, J = 6.3 Hz), 2.45 (s, 2H), 2.26 (s, 2H), 2.04 
(d, 4H, J = 7.8 Hz), 1.86 (t, 4H, J = 8.2 Hz), 1.78 (d, 4H, J = 6.9 Hz), 1.67 (s, 4H), 1.59 – 
1.49 (m, 12H), 1.42 (d, 4H, J = 9.3 Hz), 0.99 (t, 4H, J = 11.1 Hz).  13C NMR: δ (ppm) =  
175.43 (trans CO2), 174.95 (cis CO2), 69.16 (trans –CH2OCO), 68.41 (cis –CH2OCO), 66.95 
(trans –CH2OH), 42.60 (trans –OCOCH-), 40.75 (cis –OCOCH-), 37.11 (trans –OCH2CH-), 
34.53 (cis –OCH2CH-), 28.86 (trans cyclic –CH2- [CHC]), 28.08 (trans cyclic –CH2- 
[CDM]), 26.04 (cis cyclic –CH2- [CHC]), 25.32 (cis cyclic –CH2- [CDM]). 
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3.2.4 Elastomer Synthesis 
Elastomer Synthesis Using 2-Isocyanatoethyl Methacrylate.  Colorless elastomers 
were prepared according to the following procedure.  A 500-mL round bottom flask was 
charged with a calculated amount of hydroxyl-endcapped prepolymer (2 – 25 g).  The flask 
was evacuated and then purged with N2 three times.  A condenser was attached to the flask, 
and 50 mL of CH2Cl2 were added.  The solution refluxed under N2, and stirred until the 
prepolymer completely dissolved.  2-Isocyanatoethyl methacrylate (4.2 mol equiv, according 
to the ‹Mn› of the prepolymer as determined by 1H NMR) was added to the flask along with 
0.01 wt % Sn(Oct)2.  The contents were refluxed for 1 h, and the solvent was removed under 
reduced pressure.  The methacrylate-endcapped prepolymers were purified by precipitating 
the contents in cold methanol (–78 °C) and removing the methanol under reduced pressure.  
Elastomers were fabricated by first adding 0.5 wt % 2,2-diethoxyacetophenone to the 
purified prepolymer.  To ensure that the resulting films were homogeneous, the contents 
were thoroughly stirred at room temperature after initiator addition.  Films were prepared by 
pouring the prepolymer liquid into 5 cm × 5 cm teflon molds and irradiating them with 30 
mW/cm2 UV irradiation (365 nm) for 10 min.  The cured films were dried in a vacuum oven 
at 80 °C for 5 d.     
Elastomer Synthesis Using Methacryloyl Chloride.  Colorless elastomers were 
prepared according to the following procedure.  A 25-mL round bottom flask was charged 
with a calculated amount of hydroxyl-endcapped prepolymer.  The flask was evacuated and 
heated to remove any air or moisture, and then purged with N2.  This was repeated three 
times.  A condenser was attached to the flask and approximately 15 mL of CH2Cl2 were 
added.  The solution refluxed under N2 and stirred until the prepolymer completely dissolved.  
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Triethylamine (4.2 mol equiv, according to the ‹Mn› of the prepolymer as determined by the 
GPC or NMR) was added to the flask and stirred for 5 min.  After the contents were cooled 
to 0 °C using an ice bath, methacryloyl chloride (4.2 mol equiv, according to the ‹Mn› of the 
prepolymer as determined by the GPC or NMR) was added slowly, and the contents stirred 
overnight.  The contents were washed twice with 1M HCl, NaHCO3 (3%), deionized H2O, 
brine, and finally dried with MgSO4.  The solution was filtered and the solvent was removed 
under reduced pressure.  The residue was precipitated in cold methanol (–78 °C).  The curing 
procedure was identical to the method used for the elastomers prepared using 2-
isocyanatoethyl methacrylate.  
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Scheme 1.  Shape-memory elastomer fabrication (only trans-isomers depicted) 
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3.3 Results and Discussion 
3.3.1 Polyester Prepolymer Structure and Thermal Properties   
Six hydroxyl-terminated PCCD prepolymers were synthesized with different number-
average molecular weights in order to vary the thermal properties of the resulting elastomers.  
The molecular weights, percentages of trans 1,4-cyclohexanedicarboxylate isomers, and 
glass transition temperature values for the prepolymers are shown in Table 3.1. 
 
Table 3.1  Polyester prepolymers synthesized at 130 °C, 20 – 0.1 mmHg, and 48 h 
Sample ‹Mn› × 10-3 (g/mol)a ‹Mn› × 10-3 (g/mol)b CHCtrans (%)c Tg (°C)d 
PCCD1 0.6 1.0 26.5 –20 
PCCD2 1.1 2.0 25.7 1 
PCCD3 1.7 2.7 26.8 9 
PCCD4 2.2 4.0 27.8 14 
PCCD5 2.8 5.0 27.7 25 
PCCD6 8.3 25.0 26.0 36 
aBased on 1H NMR analysis.  bTarget molecular weights.  cPercentage of trans isomers of 
1,4-cyclohexanedicarboxylate repeat units.  dBased on DSC analysis. 
   
Controlling the cis/trans ratio of chair conformations in PCCD, specifically those of 
the CHC isomer, is very important as it directly impacts the polymer morphology.1-3 
Specifically, PCCD materials that contain >87% of the trans-CHC isomer are 
semicrystalline.4 The feed CDC used in this study contained a low amount of trans isomer 
(23.7 %), and little isomerization occurred during the polymerization, which resulted in 
completely amorphous materials.   
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Although the number-average molecular weights of PCCD1 – PCCD5 were quite 
similar, ranging from 0.6 – 2.8 × 103 g/mol based on 1H NMR analysis, their glass transition 
temperatures ranged from -20 – 25
 
°C.  PCCD6 had the highest molecular weight (‹Mn› = 8.3 
× 103 g/mol) and a glass transition temperature of 36 °C.  GPC analysis measured ‹Mn› = 1.6 
– 7.7 × 103 g/mol for samples PCCD2 – PCCD6, with PDI values that ranged from 1.7 – 1.9.  
The molecular weights were analyzed by 1H NMR and GPC because the molecular weight of 
PCCD1 was below the detection limit of the GPC columns used in this study.  The measured 
number-average molecular weights for PCCD2 - PCCD6 did not correspond well with the 
target molecular weights, which may be due to low monomer reactivity, high reaction 
viscosity, or catalyst choice; however, these potential causes were not investigated because 
the desired thermal properties were obtained. 
1H NMR, 13C NMR, and FTIR analysis confirmed that the prepolymers were 
exclusively hydroxyl terminated.   1H NMR analysis showed signals at δ = 3.42 and 3.52 
ppm, which corresponded to hydroxyl endgroups, but none that corresponded to carboxyl 
endgroups (δ = 2.15 and 2.35 ppm).  13C NMR also showed signals for hydroxyl endgroups 
at δ = 69 ppm, but none for carboxyl endgroups at δ = 176 ppm.  FTIR spectra displayed 
broad peaks at 3500 cm-1 and sharp peaks at 1735 cm-1, which corresponded to hydroxyl 
groups and (ester) carbonyl groups, respectively; however, signals that corresponded to 
carboxyl endgroups (3300 or 1700 cm-1) were not observed.  As representative examples, the 
1H NMR and 13C NMR spectra for PCCD5 are shown in Figure 3.1, and the FTIR spectrum 
for PCCD3 is shown in Figure 3.2. 
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Figure 3.1 1H NMR spectrum (above) and 13C NMR spectrum (below) of PCCD5, 
representative of all PCCD prepolymers 
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Figure 3.2  FTIR spectrum for PCCD3, representative of all PCCD prepolymers 
 
3.3.2 Prepolymer Endcapping   
PCCD1 – PCCD6 were endcapped with 2-isocyanatoethyl methacrylate after 1 h in 
refluxing CH2Cl2.  1H NMR analysis confirmed that the endcapping reactions were nearly 
quantitative (>99%), as shown in Figure 3.3.  The top spectrum displays the endgroup α-
hydrogens for the unreacted prepolymer (δ = 3.52 and 3.44 ppm).  After reacting with 2-
isocyanatoethyl methacrylate those signals disappeared, as shown in the middle 1H NMR 
spectrum in Figure 3.3.  The bottom spectrum is of the purified methacrylate-endcapped 
prepolymers, which shows two distinct quartets (δ = 3.59 (c’) and 3.47 (c”) ppm) with 
identical coupling constants (J = 5.4 Hz) and corresponded to the aforementioned endgroup 
α-hydrogen signals in relative integrations (0.39/1.00 for c’/c” and 0.43/1.00 for a/b).   
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Figure 3.3  1H NMR spectrum of a hydroxyl-terminated prepolymer (a:cis; b:trans) (top), 
conversion NMR of an endcapping reaction (middle), and methacrylate-terminated 
prepolymer (c’: cis-conformation; c”: trans-confromation) (bottom) 
  
 Quantitative conversions are only rarely reported for endcapping reactions.  For 
example, Langer et al. used methacryloyl chloride to crosslink a number of poly(glycerol-co-
sebacate) copolymers and achieved degrees of acrylation that ranged from 17 – 54 %.5  Also, 
Liu et al. reported endcapping conversions of 80 – 95 % when methacryloyl chloride was 
used as the endcapping reagent.6 In addition to the obvious synthetic advantages, achieving 
quantitative conversions during the preparation of biomedical devices minimizes the 
presence of leachables in the final product, which can induce toxic responses.7 Here, the 
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possibility of producing toxic materials was minimized and the synthetic conditions were 
optimal. 
3.3.3 Elastomer Formation   
The methacrylate-endcapped prepolymers were then crosslinked using UV 
irradiation.  The thermal properties for the six elastomers are displayed in Table 3.2.   
 
Table 3.2  Thermal data for SMP1 – SMP6  
Samplea E”max (°C)b Tan δmax (°C)b Weight Loss (°C)c 
   5% 10% 
SMP1 73 140 249 310 
SMP2 48 114 221 306 
SMP3 36 85 290 337 
SMP4 25 66 276 345 
SMP5 22 80 324 376 
SMP6 40 54 383 426 
 
aElastomer number correlates with prepolymer nomenclature.  bMeasured using DMA; loss 
modulus; temperature at peak of the tan δ curve.  cPercent weight loss as determined by TGA. 
 
Both the E”max and the tan δmax, along with other transitions, have been used as 
reference points for a material’s glass transition temperature.8 Here, the tan δmax values were 
used to estimate the glass transition temperatures.  The tan δ values generally decreased with 
increasing prepolymer molecular weights and were relatively broad, as measured by the full-
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width at half-maximum values (tan δFWHM = 23 – 110 °C; Figure 3.4).  The thermal 
transitions were broad regardless of the heating rate (1, 2, or 10 °C/minute). 
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 Figure 3.4  Glass transition temperatures and tan δFWHM values for SMP1 – SMP6 
 
A comparison of the thermal properties of SMP4 and those of a corresponding 
elastomer prepared with methacryloyl chloride (SMP4*) showed that the broad transitions 
did no originate from the presence of urethane groups (Figure 3.5).  The broad transitions 
also did not originate from the prepolymers, as only narrow and very distinct glass transitions 
were observed in the DSC thermograms.     
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Figure 3.5  Tan δ curves for SMP4 and SMP4* (SMP4 tan δFWHM = 55 °C; SMP4* tan 
δFWHM = 50 °C) 
 
The only shape-memory materials that have displayed such broad transitions have 
been nanocomposites.9-11 Most notably, Poulin et al. prepared poly(vinyl alcohol)-carbon 
nanotube shape-memory nanocomposites with broad glass transitions that possessed both 
shape-memory and temperature-memory properties.12 To our knowledge, the PCCD-based 
elastomers presented here are the first examples of biodegradable shape-memory materials 
with such broad transitions.  An investigation into their impact on the shape-memory 
properties was made.   
3.3.4 Shape-Memory Packaging   
Instron analysis at different temperatures was conducted to determine the ideal 
packaging temperatures for SMP3, SMP4, and SMP6 (Figure 3.6).  Ideal packaging 
temperatures were correlated with the highest observed strains.  Because of the broad thermal 
transitions, there were wide ranges of possible packaging temperatures for each material, 
which is not common among most SMPs.  The ideal packaging temperatures for the three 
materials was approximately 5 °C below the Tg values.  For SMPs with narrower transitions, 
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packaging at temperatures just below the Tg is crucial as it minimizes irreversible bond 
breakage and yields a better thermal response.13 The SMPs presented here are advantageous 
as their elastic properties are not confined to temperatures near the Tg values. 
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Figure 3.6  Strain at break (%) and tan δ values plotted against temperature (°C) for SMP3, 
SMP5, and SMP6; error bars represent one standard deviation from the average 
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3.3.5 Shape-Memory Recovery   
Given that ideal biomedical SMPs bear thermal transitions near body temperature (37 
°C),14 SMP6 (Tg = 54 °C) was the most promising.  For comparison, other SMPs that have 
been studied as biomedical devices have had thermal transitions of 51 °C, 53 °C, 53 °C, 55 
°C, and 65 °C.14-18 
 The two quantitative measurements that are important for shape-memory 
characterization are the strain fixity rate Rf and the strain recovery rate Rr, which quantify the 
ability of an SMP to be packaged and recover.  The Rf and Rr values for five cycles, as well 
as the maximum stress (εmax) values are displayed in Table 3.3.   
 
Table 3.3  σmax (MPa) values, Rf (%) values, and  Rr (%) values for five shape-memory 
cycles for SMP6 packaged at 49 °C and recovered at 64 °C 
 
Cycle number 1 2 3 4 5 
σmax (MPa) 3.4 4.8 4.7 4.4 4.2 
Rf (%) >99 >99 >99 >99 >99 
Rr (%) - 98.2 >99 >99 >99 
 
Table 3.3 clearly shows that SMP6 exhibited ideal shape-memory properties up to 
five cycles.  Shape-memory properties typically improve with increasing cycles because the 
irregularities in the network have been relaxed and reoriented during previous cycles.18 This 
same trend is seen here with a Rr value of 98.2 % for the 2nd cycle and nearly quantitative 
values starting with the 3rd cycle.  The samples broke near ε = 200 % at the sixth or seventh 
cycle, so those data were omitted.  To our knowledge, there have been no previous reports of 
shape-memory studies of degradable, amorphous SMPs conducted at such high strains (ε ≥ 
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200 %), which demonstrates the potential of these materials as biomedical SMPs.  
Furthermore, the general trend of amorphous SMPs with compromised Rr values was not 
observed, with the recorded values being greater than 96.6 %.  An example of a recovery 
process for SMP6 is shown in Figure 3.7.  The sample was packaged to a more confined state 
(top right).  The sample recovered the original shape (bottom right) in 6 seconds at 64 °C 
(clockwise). 
 
   
 
   
 
Figure 3.7  The recovery process for SMP6 at 64 °C (total time: 6 sec; scale bar = 5mm) 
   
3.3.6 Potential as Biomedical Devices   
These SMPs possessed good shape-memory properties, as exemplified by SMP6.  In 
order to assess their capabilities as biomedical devices, the probability of these materials 
inducing a cytotoxic response was tested.  Neat (SMP3, SMP5, and SMP6) and extracted 
(exSMP3, exSMP5, and exSMP6) all scored 0 according the ISO 10993-5 standard, which 
indicated no cytotoxic response, although further tests are required to ascertain whether they 
are biocompatible. 
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3.3.7 Necessity of Extraction Step   
Because the neat samples did not induce a cytotoxic response, the necessity of an 
extraction step was examined.  Table 3.4 displays the thermal properties of the extracted 
materials along with solvent uptake and soluble fraction data. 
 
Table 3.4  Thermal uptake, solvent uptake, and soluble fraction data for extracted SMP1 – 
SMP6 
 
Sample E”max(°C) tan δmax (°C) ζ (%)a Qs (%)b Weight Loss (°C) 
         5% 10% 
ExSMP1 49 142 68 9.2 241 300 
ExSMP2 44 120 101 11.0 220 307 
ExSMP3 30 81 118 7.9 337 359 
ExSMP4 20 70 221 10.0 337 364 
ExSMP5 23 71 251 6.2 348 396 
ExSMP6 50 61 583 11.6 386 443 
 
aSwelling ratio.  bSolution fraction. 
 
DMA analysis showed that the extracted films retained their original mechanical and 
thermal properties.  Thermal gravimetric analysis was performed on the fully dried materials 
to prove that no solvent remained in the fully-dried films.  The tan δmax values, tan δFWHM 
values, and E”max values for the neat samples and the extracted films were all very similar, 
regardless of the prepolymer molecular weight (Figure 3.8).   
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Figure 3.8  Tan δmax (top), tan δFWHM values (middle), and E”max values for SMP1-SMP6 and 
ExSMP1 – ExSMP6 
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The results from cytotoxicity and DMA analysis indicated that the extraction step did 
not change the thermal properties or the mechanical properties.  Furthermore, the neat 
samples were nontoxic, so an extraction step was not required to improve the cytotoxic 
response.  These results indicated that an extraction step was an unnecessary processing step 
for these SMPs. 
3.4 General Conclusions 
Several amorphous thermoset elastomers were synthesized based on poly(1,4-
cyclohexanedimethanol 1,4-cyclohexanedicarboxylate), and their structure and thermal 
properties were characterized.  Six crosslinked amorphous elastomers were prepared, and 
their thermal properties were described.  Because of their broad transitions, these materials 
were able to be packaged at a wide range of temperatures.  The shape-memory properties 
were demonstrated at the nominal packaging and recovery temperatures for SMP6, which 
exhibited exemplary shape-memory properties (Rf and Rr > 99 % after five cycles).  An 
extraction step was deemed as an unnecessary processing step for these materials according 
to DMA analysis.  Furthermore, these materials were nontoxic according to the ISO-10993-5 
standard.    
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4.1 Introduction 
Currently, SMP devices such as self-tightening sutures and self-deployable stents are 
designed to undergo total, delocalized, changes in shape (Figure 4.1; top).1-4 In this regard, 
the amorphous materials highlighted in Chapter III were quite promising.  In particular, 
SMP6 was measured as having almost quantitative strain fixity rates and strain recovery rates 
when packaged at high strains (ε = 200 %) for five shape-memory cycles.  However, there 
are several biomedical applications that would benefit from devices that exhibit localized 
shape-memory changes, such as changes in porosity or surface pattern. 
              Permanent Shape     Temporary Shape                   Permanent Shape 
 
Packaging             Recovery 
 
                               
Figure 4.1  Representation of delocalized (top) and localized (bottom) shape changes 
   
Recently, there has been a great deal of interest in porous scaffolds as degradable 
scaffolds,5 drug delivery devices,6,7 vehicles for DNA transport,8 host systems,9 separation 
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devices,10 and adsorbents.11 As my interests involve biomedical SMPs, the studies discussed 
here focus on the use of porous SMPs as drug delivery and degradable devices.  In theory, 
porous materials could be fabricated, packaged as a closed-pore flattened system, and 
inserted in vivo.  The initial degradation or drug release kinetics would be observed until a 
thermally-induced pore-opening transition occurred that would change the kinetics.  To my 
knowledge, there have been no studies on a thermally-induced transition involving a porous 
material that causes an increase or decrease in surface area for use as drug delivery or 
degradable devices.   
Another interesting transition is from a patterned surface to a non-patterned surface, 
or vice versa.  Biomedical applications that require switches in tissue adhesion, cell growth 
or differentiation, implant removal, flow rates, drug release kinetics, degradation profiles, 
vessel expansion, more efficient drug delivery devices, or hydrophobicity would benefit from 
surface-switching polymers (SSPs). 
The first reports of SSPs described their potential as adhesive switches, sensors, or 
microfluidic devices.12,13 Microfeatures were imprinted on the permanent or temporary states 
of the shape-memory polymer using standard lithographic techniques.  Features that were 
imprinted in the permanent shape-memory state could be deformed by applying a separate 
mold at higher temperatures, and the original pattern could then be recovered with 
subsequent heat.  Although these reports described the first SSPs, the imprinted feature sizes 
were relatively large (>87 µm).  Furthermore, there were no reports of complete surface 
structure changes, as permanent features were only deformed.   
Here, two methods were used to study the possibilities of SSPs as biomedical devices.  
First, nonporous and porous scaffolds of SMP5 (Chapter III) were prepared using a salt-
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leaching method, and the drug release kinetics as well as the degradation profiles of both 
states were measured.  The preliminary results from these studies assessed whether a 
transition from a nonporous material to a porous material, or vice versa, could create more 
intelligent biomedical devices.   
Second, SSPs with nanoscopic shape-changing capabilities and their fabrication 
methods are presented.  Several microscopic and nanoscopic surface structures were formed 
on shape-memory materials using Particle-Replication in Non-wetting Templates (PRINTTM ) 
technology.14-17 Using standard lithographic techniques, complete structure transformations 
were observed.  Furthermore, this account describes the smallest shape-memory changes ever 
recorded using a stamping method.  The technology that was used to fabricate these SSPs, 
their biomedical applications, as well as the results from the nonporous/porous studies are 
discussed. 
4.2 Experimental Section 
4.2.1 Materials 
All materials were purchased from Aldrich unless otherwise noted.  The analyzed 
polymer is SMP5 from Chapter III (Ttrans = 80 °C).  The PRINTTM molds and corresponding 
materials were prepared according to the literature.14-17 
4.2.2 Characterization 
 High performance liquid chromatography (HPLC) measurements were performed 
using a Waters 2695 Separation Module with a 4.6 × 150 mm Atlantis column with C18 5µm 
particles and a Waters dual wavelength detector (λ = 350 nm).  A solvent gradient with two 
solvents (A: 95 % water, 4.9 % acetonitrile, and 0.1% trifluoroacetic acid and B: 95 % 
acetonitrile, 4.9 % water, and 0.1 % trifluoroacetic acid) was used where solvent B was 
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increased from 0 – 40 % in 12 min.  The amount of minocycline in the sample was calculated 
using the area under the peak at t = 9.1 min.  Images were recorded using scanning electron 
microscopy (Hitachi model S-4700). 
Porous films were prepared by mixing a NaCl/polymer mixture (10:1 wt %), curing 
for 10 min using UV irradiation as described in Chapter III, and then soaking in water several 
times to remove the excess salt.  The resulting porous scaffolds were dried in a vacuum oven 
at 25 – 40 °C for several days.  Nonporous scaffolds were prepared according to the methods 
described in Chapter III. 
Elastomer films (0.15 g) were placed in pH 5 and 0.01 M pH 7.4 phosphate buffer 
saline solutions at 37 °C.  At the prescribed intervals, each swollen network was removed 
from the buffer solution and blotted dry, and the mass was recorded.  The water uptake (WU) 
was calculated according to the following equation  
100×−=
d
ds
m
mm
WU  
where ms and md represent the swollen and dry mass, respectively.  The value was reported as 
the average of three measurements.  All error bars represent one standard deviation. 
Nonporous and drug-infused nonporous scaffolds were prepared by mixing 2.5 wt % 
minocycline in the prepolymer and using salt-leaching methods for the porous samples, 
which were then cured with subsequent UV irradiation.  Samples were placed in pH = 5 or 
0.01 M pH = 7.4 phosphate buffer saline solutions at 37 °C, where the mass (g) of solution 
equaled ten times the mass (g) of sample, and the buffer was changed daily.  Aliquots (30 
µL) were analyzed daily using an HPLC with an acetonitrile/H2O gradient.  Control samples 
included porous and nonporous samples of SMP5 at pH = 5 and pH = 7.4.  Each 
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measurement was done in triplicate, and the amounts of released minocycline were 
calculated using a calibration curve of minocycline (exposed to UV irradiation). 
Elastomer films (0.15 g) were placed in pH = 5 and 0.01 M pH 7.4 phosphate buffer 
saline solutions at 37 °C.  The films were removed from the buffer solution at the prescribed 
intervals and dried under vacuum for 24 h before their mass was measured.  Each 
measurement was performed on three separate samples.  All error bars represent one standard 
deviation.  Mass loss (ML) was calculated according to the following equation 
100×−=
i
ti
m
mm
ML  
where mi and mt represent the initial mass and mass at time t. 
4.3 Results and Discussion 
4.3.1 Drug Delivery SSP   
SEM images of the porous and nonporous scaffolds used in the drug delivery and 
degradation studies are shown in Figure 4.2.  The drug release kinetics of minocycline, an 
anti-inflammatory antibiotic,18 for porous and nonporous samples of SMP5 were measured 
for 10 d (Figure 4.2).  Nearly identical calibration curves for minocycline exposed to UV 
radiation and unexposed minocycline were measured, which indicated that the minocycline 
was not affected during the curing step.  The drug release kinetics were measured at pH = 5 
and pH = 7.4 to mimic the intracellular and intercellular environments, respectively.  Control 
samples of porous and nonporous materials containing no minocycline were also measured 
and showed negligible signals.   
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Figure 4.2  SEM images of nonporous and porous samples of SMP5 
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Figure 4.3 Drug release profile for minocycline-infused SMP5 at pH = 5 and pH = 7 for 10 d 
 
Figure 4.3 shows nearly identical release profiles for all of the samples, which can be 
best described as initial “bursts” followed by a more constant rate of release.  These results 
correlated with the most common release profiles in polymer drug delivery devices and 
indicated that these materials were promising as drug delivery scaffolds.19 However, there 
were no differences in the release profiles of the porous and nonporous scaffolds outside of 
experimental error.   
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Contrary to these results, the amount of surface area has been reported as an 
important factor in the release kinetics of drug delivery devices.  Recently, Horcajada et al. 
reported an unprecedented zero-order release of ibuprofen from flexible, porous metal-
organic frameworks, which were attributed to the ‘breathing effect’ of the porous material 
upon hydration.6 Langer et al. also reported the benefits of porous drug delivery devices 
relative to their nonporous counterparts.7 The systems reported here were not optimized, and 
so further experiments are required to assess the potential of drug delivery SSPs.  Ideal SSP 
drug delivery devices would contain temporary and permanent states that exhibit quite 
different drug release kinetics.  In order to achieve such a device, more sophisticated methods 
of controlling surface area are required.  Currently, efforts are underway to fabricate more 
controlled drug delivery devices and will be discussed in Chapter V. 
4.3.2 Degradation Studies   
Another interest in the porous/nonporous transition was the fabrication of intelligent 
degradable materials.  The same porous and nonporous scaffolds used in the drug delivery 
studies were used here (SMP5), and the studies were also conducted at pH = 5 and pH = 7.  
The results of the 6-week degradation study are shown in Figure 4.4.   
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Figure 4.4  Degradation profiles for SMP5 (mass loss (%) vs. time (d)) 
 
The differences between the nonporous and porous samples were very distinct; the 
nonporous samples did not show any appreciable degradation whereas the porous materials 
were nearly completely degraded at the end of the 6-week study.  It was very clear that the 
two states of a flattened, nonporous sample and a porous sample may indeed show different 
degradation kinetics after a shape-memory transition.  The study of a transition from a 
flattened, nonporous system to a porous system and the effect on degradation kinetics is 
currently underway.   
4.3.3 Creating SSPs Using PRINTTM Technology   
The general methods by which SSPs were fabricated using PRINTTM technology is 
shown in Figure 4.5.   
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METHOD 1 
                               
          (A1)                    (B1)                        (C1)                       (D1)                      (E1) 
 
METHOD 2 
                              
                               (A2)                              (B2)                               (C2) 
                              
                               (F2)                               (E2)                               (D2) 
Figure 4.5  Methods for creating SSPs using PRINTTM technology 
 
 Method 1 involved having a flat, non-patterned surface as the permanent state and a 
patterned surface as the temporary state.  A SMP material was cured using the conditions 
described in Chapter III (A1).  In order to fabricate a patterned surface, a PRINTTM mold 
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with the appropriate negative dimensions was first fabricated (B1; top).14-17 The patterned 
mold was then applied to the non-patterned SMP at elevated temperatures (C1).  After 1 h, 
the applied mold and SMP were cooled below the SMP transition temperature (T = 0 °C).  
The mold was then removed, which revealed temporary surface features (D1).  The original, 
flat surface was then recovered by raising the temperature above the SMP transition 
temperature (T = 110 °C) (E1).  Method 2 involved having a patterned surface as the 
permanent state and a differently patterned surface as the temporary state.  A PRINTTM mold 
was first fabricated (A2; top) and then applied to a SMP prepolymer liquid, which was cured 
using UV radiation (B2).  Having the mold applied to the prepolymer liquid created 
permanent surface features following mold removal (C2; bottom).  A new, differently 
patterned PRINTTM mold was then introduced (C2; top) and applied to the SMP surface at 
elevated temperatures (D2).  After 1 h, the applied mold and SMP were cooled below the 
SMP transition temperature.  The mold was then removed, which revealed temporary surface 
features (E2).  The original, permanent pattern was then recovered by raising the temperature 
above the SMP transition temperature (F2).  The use of these two methods proved successful 
as shown in Figure 4.6 and Figure 4.7. 
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Figure 4.6  Temporary 200 × 36 nm features (middle) were imprinted on the original 
permanent polymer surface (left) and then thermally “erased” (right); scale bar is 3 µm 
 
 
 
Figure 4.7  Temporary 3 µm × 3 µm × 3 µm cubes (middle) were imprinted on a permanent 
hexnut-patterned surface with similar feature sizes (left), which were recovered upon the 
application of heat (right); scale bar is 10 µm 
 
4.4 General Conclusions 
 These methods could create more intelligent biomedical devices that change in their 
adhesive properties,20 optical properties,21 cell response,22 or surface area, thereby changing 
degradation kinetics, drug delivery kinetics, flow rates, separation properties, or adsorbent 
properties.  Changing surface topography could also aid the inhibition of catheter-related 
thrombosis.23 The use of SSPs as biomedical implants could also lengthen device lifetimes by 
introducing an entirely new surface to the body in vivo.  Furthermore, creating a new surface 
may aid in implant or catheter removal, which is problematic due to hemorrhaging at the site 
of catheterization.24-26  The ease of fabrication of these SSPs make this process industrially 
practical, and the versatility of PRINTTM technology indicates that the full scope of these 
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materials has yet to be seen.  Chapter V discusses current work, future research directions, 
and potential new applications for this process. 
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5.1 General Conclusions 
This dissertation focused on the synthesis and fabrication of novel SMP poly(ester 
urethane)s that were then optimized for use in the biomedical field.  Chapter II discussed the 
synthesis of amorphous poly(ester urethane)s based on novel soft segments and MDI.    
These materials degraded appreciably in 6 weeks in physiological conditions and underwent 
a surface segregation phenomenon upon contact with water.  All but one material did not 
elicit a cytotoxic response during the 1-week testing period even using two separate 
sterilization methods.  These materials were promising as degradable, elastic implants; 
however, their utility as SMPs was minimal due to their low thermal transitions (Tg = -46 – 
18 °C). 
Chapter III described the utility of SMP thermosets based on poly(1,4-
cyclohexanedimethanol 1,4-cyclohexanedicarboxylate) prepolymers.  Six prepolymers were 
synthesized at varying molecular weights and their thermal properties spanned a broad range 
of temperatures (Tg = -20 – 36 °C).  These prepolymers were cured photochemically resulting 
in nontoxic elastomers with Tg = 54 – 140 °C.  SMP6 (Tg = 54 °C) was promising as a 
biomedical SMP (Rf > 99%, Rf > 99%, ε = 200 %).   The necessity of an extraction step was 
deemed unnecessary, as it was proved to have no effect on the thermal properties or the 
mechanical properties. 
Chapter IV introduced the concept of surface-switching polymers (SSPs).  Although 
the preliminary tests of a porous to nonporous transition of SMP5 (Tg = 80 °C) showed no 
promise as a drug delivery device, the utility of such a transition as a method for induced 
degradation was promising.  In an effort to optimize the processes that control changes in 
surface area and patterning, SSPs were created using PRINTTM technology.  Erasable or 
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changeable nanoscopic and microscopic structures were created with high fidelity.  The 
reports presented in Chapter IV were the smallest recorded shape-memory surface changes 
using stamping methods and are quite promising for a number of biomedical applications. 
5.2 Research Directions  
As discussed in Chapters III and IV, there has been a great deal of recent interest in 
porous materials.  Using PRINTTM technology to create these materials with controlled 
porosity should be pursued in order to better investigate the use of porous SSPs as drug 
delivery devices and degradable implants.  SSPs could also be useful for the removal of long 
indwelling implants by changing surface pattern in vivo.  The investigation of surface 
interactions with tissues is required to fully assess the potential of SSP coatings.   
 Stimuli other than direct heat should be studied to induce a change in SSPs.  
Composite materials have been studied as SMPs, and the use of magnetic particles,1 metal 
nanoshells,2 or carbon nanotubes,3 could be incorporated in SSPs for a magnetically-, IR-, or 
electrically-induced surface transition, respectively.  Magnetically-induced transitions could 
be very promising for SMP actuator biomedical devices with the use of magnetic resonance 
imaging (MRI) instruments.  For example, patterned or nonpatterned implants could be more 
easily removed following an MRI scan.   
 Shape-memory nanoparticles could be fabricated using PRINTTM technology.  By 
laminating a SMP prepolymer on a non-wetting template, particles could be fabricated and 
then deformed according to the literature.4 The original nanoparticle shape could then be 
recovered either thermally or, if it is a composite, according to the previously listed stimuli.  
The investigations of shape-changing particles could include flow dynamics, aggregation 
control, delivery dynamics, or biological recognition.   
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Although this dissertation focused on the fabrication of thermally-responsive 
biomedical devices, SSPs may be useful in other areas as well, such as data storage devices. 
Previous accounts of such devices include a system that nanoscopic patterns formed using 
multiple atomic force microscopy tips that could be subsequently erased thermally.5 
Although this method was deemed promising for commercial applications, it was highly 
energy-intensive with only 0.2 % of the heating power used for writing data.  Furthermore, 
pattern-to-pattern transitions could not be realized using this writing method.  The use of 
SMP actuators from a less cost-intensive stamping technique could create a novel data 
storage system. 
 Finally, the concepts of SSPs or SMP nanoparticles should not be limited to 
thermally-responsive shape-memory polymers.  Materials that are pH-responsive, 
photoresponsive, contain a lower critical solution temperature (LCST) or an upper critical 
solution temperature (UCST), or responsive to other stimuli are also promising as surface-
switching devices. 
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Introduction 
In this appendix, the synthesis of novel aminediols is reported (Scheme 1).  Their 
synthesis as well as the subsequent polymerization with adipoyl chloride is described.  
Current efforts are underway that study the thermally-responsive nature of the amine-
functionalized polyesters. 
   
 
Scheme 1.  Hydroboration of amine-functionalized diene 
Experimental Procedure 
Materials.  All reagents were purchased from Aldrich and used as received unless 
noted otherwise.  1,4-Butanediol was distilled and stored on 4 Å molecular sieves prior to 
use. 
Characterization.  1H and 13C NMR spectra were acquired in deuterated chloroform 
or water on a Bruker 400 AVANCE.  Thermogravimetric analysis was performed on a 
PerkinElmer Pyris 1 TGA with a heating rate of 10 °C/min in a N2 atmosphere.  Glass 
transition temperatures were measured with a Seiko 220C differential scanning calorimeter, 
using a heating rate of 10 °C/min and a cooling rate of 10 °C/min in a N2 atmosphere.  Glass 
transitions were determined at the inflection point of the endotherm.  Mass spectra were 
obtained using a Bruker BioTOF II reflection time-of-flight (reTOF) mass spectrometer 
equipped with an Apollo electrospray ionization (ESI) source.  The samples were prepared in 
a 99:1 methanol:acetic acid solution, infused into the electrospray source at 65 µL/hr, and 
positive mode electrospray ionization was used to generate the ions.  Mass spectra were 
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obtained using a Bruker Ultraflex MALDI-TOF mass spectrometer equipped with a Nitrogen 
continuous-flow long lifetime laser MNL205, 337 nm.   
Monomer Synthesis.  Compounds 2-(N,N-dimethylaminomethyl)-1,3-butadiene, 2-
(N,N-diethylaminomethyl)-1,3-butadiene, and 2-(N,N-dipropylaminomethyl)-1,3-butadiene 
were synthesized and purified as described previously.1 
Amine-functionalized 1,4-butanediol compounds Diols 1,2, and 3.  A typical synthesis 
is as follows.  A 0.5 M solution of 9-borobicyclo[3.3.1]nonane (41.4 g, 340 mmol) (9-BBN) 
in THF was added dropwise to a stirring solution of 2-(N,N-dimethylaminomethyl)-1,3-
butadiene (14.5 g, 131 mmol) and 100 mL THF at 70 °C.  After 20 h, 3 M NaOH (167 mL) 
was added dropwise to the solution, which was then cooled to 0 °C.  A 30 % solution of 
hydrogen peroxide (167 mL) was then added very slowly so as to keep a gentle reflux.  The 
water layer was saturated with potassium carbonate, and the product was extracted with ethyl 
acetate.  Excess solvent was removed under reduced pressure and the remaining residue was 
purified using a column (ethyl acetate and then methanol as the eluents).  The product was 
distilled under vacuum twice, which afforded Diol 1 in 40.6 % yield.    
2-(N,N-dimethylaminomethyl)-1,4-butanediol (Diol 1).  1H NMR (CDCl3): δ (ppm) = 
5.10 (s, 2H), 3.59 (m, 4H), 2.50 (m, 2H), 2.30 (s, 6H), 1.95 (m, 1H), 1.58 (m, 1H), 1.41 (m, 
1H).  13C NMR (CDCl3): δ (ppm) = 67.16 (-CHCH2OH), 63.97 (-CH2CH2OH), 60.86 (-
CHCH2N(CH3)2), 45.28 (-CH2N(CH3)2), 36.87 (-CHCH2N(CH3)2), 34.39 (-CH2CH2OH).  
Theoretical mass was calculated to be 148.134 g/mol; high-resolution mass spectrometry 
showed a measured mass of 148.132 g/mol.  
2-(N,N-diethylaminomethyl)-1,4-butanediol (Diol 2).  1H NMR (CDCl3): δ (ppm) = 
4.66 (s, 2H), 3.61 (m, 4H), 2.52 (m, 6H), 1.98 (s, 1H), 1.49 (m, 1H), 1.37 (m, 1H), 1.03 (t, 
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6H, J = 7.2 Hz).  13C NMR (CDCl3): δ (ppm) = 68.02 (-CHCH2OH), 60.94 (-CH2CH2OH), 
58.70 (-CHCH2N(CH2CH3)2), 46.94 (-CH2N(CH2CH3)2), 36.32 (-CHCH2N(CH2CH3)), 34.28 
(-CH2CH2OH), 11.08 (-CH2N(CH2CH3)2).  Yield (recovered): 39.0 %.  Theoretical mass was 
calculated to be 176.165 g/mol; high-resolution mass spectrometry showed a measured mass 
of 176.163 g/mol. 
2-(N,N-dipropylaminomethyl)-1,4-butanediol (Diol 3).  1H NMR (CDCl3): δ (ppm) = 
4.64 (s, 2H), 3.62 (m, 4H), 2.45 (m, 4H), 2.31 (m, 2H), 1.98 (m, 1H), 1.47 (m, 5H), 1.35 
(1H), 0.86 (t, 6H, J = 7.4 Hz).  13C NMR (CDCl3): δ (ppm) = 68.28 (-CHCH2OH), 60.84 (-
CH2CH2OH), 60.45 (-CH2N(CH2CH2CH3)2), 56.28 (-CH2N(CH2CH2CH3)2), 35.92 (-
CHCH2OH), 34.10 (-CH2CH2OH), 19.55 (-CH2N(CH2CH2CH3)2), 11.80 (-
CH2N(CH2CH2CH3)2).  Yield (recovered): 27.3 %.  Theoretical mass was calculated to be 
204.196 g/mol; high-resolution mass spectrometry showed a measured mass of 204.197 
g/mol. 
Adipoyl Chloride.  Adipic acid (10.2 g, 70 mmol) was added to a flame-dried three-
necked 1-L flask equipped with a condenser.  Thionyl chloride (22.2 g, 202 mmol) was 
charged to the flask.  The mixture was refluxed for 90 min.  The exhaust fumes were 
neutralized in a 5 M NaOH solution.  After 90 min, the reaction was distilled to afford 
adipoyl chloride in 90 % yield.  1H NMR (CDCl3): δ (ppm) = 2.94 (m, 4H, J = 6.7 Hz), 1.77 
(m, 4H, J = 6.8 Hz).  13C NMR (CDCl3): δ (ppm) = 173.22 (ClCOCH2-), 46.38 (ClCOCH2-), 
23.77 (ClCOCH2CH2-).   
Polyester Syntheses.  A flame-dried 25-mL round bottom was charged with the diol 
monomer and 10 mL of freshly distilled methylene chloride.  The apparatus was equipped 
with a condenser and purged with N2.  The reaction flask was charged with an equimolar 
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amount of adipoyl chloride and allowed to reflux for 1 h.  The exhaust fumes were 
neutralized in a 5 M NaOH solution.  After 1 h, methylene chloride was removed under 
reduced pressure.  Polymerization was terminated by adding 2 mL of methanol and 
precipitating the polymer into cold diethyl ether (-78 °C).  All reactions were performed on a 
1 g scale. 
Poly[2-(N,N-dimethylaminomethyl)-1,4-butanediol adipate] (PE1).  1H NMR (D2O): 
δ (ppm) = 4.22 (m, 4H, J = 6.5 Hz), 3.28 (m, 2H, J = 8.2 Hz), 3.0 (s, 6H), 2.47 (s, 4H), 2.44 
(s, 1H), 1.84 (m, 2H, J = 6.3 Hz), 1.64 (s, 4H).  13C NMR (D2O): δ (ppm) = 173.00 (-
COCH2CH2-), 61.68 (HOCH2CHCH2CH2-), 61.12 (-OCH2CHCH2CH2-), 60.19 (-
OCH2CHCH2CH2OH), 59.29 (-OCH2CH2CHCH2OH), 59.21 (-OCH2CHCH2CH2-), 58.12 
(HOCH2CH2CHCH2-), 56.77 (HOCH2CH2CHCH2N(CH3)2), 56.30 (-CHCH2N(CH3)2), 55.56 
(HOCH2CHCH2N(CH3)2), 45.85 (CH3OCOCH2-), 41.37; 39.55 (HOCH2CHCH2N(CH3)2), 
40.81 (-CH2N(CH3)2), 40.56; 40.19 (HOCH2CH2CHCH2N(CH3)2), 40.00 (-CH2N(CH3)2), 
30.44 (-COCH2CH2-), 30.29 (CH3OCOCH2-), 28.02 (-CH2CHCH2CH2-), 24.43 (-
CH2CH2CHCH2-), 20.70 (-COCH2CH2CH2CH2-). 
Poly[2-(N,N-diethylaminomethyl)-1,4-butanediol adipate] (PE2).  1H NMR (D2O): δ 
(ppm) = 4.24 (m, 4H, J = 6.5 Hz), 3.3 (m, 6H, J = 6.9 Hz), 2.49 (s, 4H), 2.45 (s, 1H), 1.88 
(m, 2H, J = 6.5 Hz), 1.67 (s, 4H), 1.34 (t, 6H, J = 7.2 Hz).  13C NMR (D2O): δ (ppm) = 
173.00 (-COCH2CH2-), 61.87 (HOCH2CH2CHCH2-), 61.18 (-OCH2CHCH2CH2-), 60.17 
(HOCH2CHCH2CH2-), 59.43 (HOCH2CHCH2CH2-), 59.35 (-OCH2CHCH2CH2-), 55.86 
(HOCH2CH2CHCH2-), 52.23 (HOCH2CH2CHCH2N(CH2CH3)2), 50.60 (-
CHCH2N(CH2CH2)2), 49.21 (HOCH2CHCH2N(CH2CH3)2), 45.95 (CH3OCOCH2-), 45.39 (-
CH2N(CH2CH3)2), 44.93 (-CH2N(CH2CH3)2), 30.56 (-COCH2CH2-), 30.42 (CH3OCOCH2-), 
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28.04 (-CH2CHCH2CH2-), 24.93 (-CH2CH2CHCH2-), 20.82 (-COCH2CH2CH2CH2-), 5.30; 
5.00 (HOCH2CHCH2N(CH2CH3)2), 5.10; 4.85 (-CH2N(CH2CH3)2).   
Poly[2-(N,N-dipropylaminomethyl)-1,4-butanediol adipate] (PE3).  1H NMR (D2O): 
δ (ppm) = 4.23 (m, 4H, J = 7.9 Hz), 3.18 (m, 6H, J = 8.7 Hz), 2.48 (s, 4H), 2.44 (s, 1H), 1.86 
(m, 2H, J = 5.8 Hz), 1.76 (m, 4H, J = 7.6 Hz), 1.65 (s, 4H), 1.00 (t, 6H, J = 7.2 Hz).  13C 
NMR (D2O): δ (ppm) = 173.00 (-COCH2CH2-), 61.26 (-OCH2CHCH2CH2-), 60.82 
(HOCH2CHCH2CH2-), 59.39 (HOCH2CHCH2CH2-), 59.32 (-OCH2CHCH2CH2-), 58.96 
(HOCH2CH2CHCH2-), 53.95 (HOCH2CHCH2N(CH2CH2CH3)2), 53.02 
(HOCH2CH2CHCH2N(CH2CH2CH3)2), 52.49 (-CH2N(CH2CH2CH3)2), 52.05 (-
CH2N(CH2CH2CH3)2), 51.52 (-CHCH2N(CH2CH2CH3)2), 46.80 (CH3OCOCH2-), 30.58 (-
COCH2CH2-), 30.44 (CH3OCOCH2-), 28.04 (-CH2CHCH2CH2-), 25.03 (-CH2CH2CHCH2-), 
20.86 (-COCH2CH2CH2CH2-), 14.00 (-CH2N(CH2CH2CH3)2), 7.27 (-CH2N(CH2CH2CH3)2).   
Results and Discussion 
Monomer Syntheses.  The disappearance of the starting materials’ alkene hydrogen 
signals (δ (ppm) = 6.38, 5.44, 5.19, 5.13, and 5.06) in the conversion 1H NMR spectra proved 
that the reactions were complete after 20 h in refluxing THF.  After the addition of sodium 
hydroxide and hydrogen peroxide, the reactions were stirred for 4 h at 25 °C to ensure that 
the intermediates were quantitatively oxidized.  A silica gel column was used to remove cis-
1,8-cyclooctanediol, the oxidized byproduct of 9-BBN, with ethyl acetate as the eluent.  The 
column was then washed with methanol to isolate the aminediols; however, the desired 
products were strongly bound to the silica gel.  As a result, Diols 1,2, and 3 were isolated in 
yields of 30 – 40 % after being distilled twice.   
 101 
Paolucci prepared polyhydroxylated indolizidines using similar purification methods.2 
Both Fleet3 and Denmark4 utilized ion-exchange columns in the purification steps to 
synthesize bis(1,3-dihydroxy-isopropyl)amine and polyhydroxylated alkaloids [(+)-
castanospermine, (+)-6-epicastanospermine, (+)-austaline, and (+)-3-epiaustraline], 
respectively.  Many attempts were made to purify the dimethylamino-, diethylamino-, and 
dipropylamino-functionalized compounds using ion-exchange columns; however, products as 
pure or dry as those obtained using silica gel columns were never afforded.   
 The 1H NMR spectra of Diols 1,2, and 3 are shown in Figure A1.  Whereas the diene 
starting materials were achiral, the three aminediol products each contain a β-hydroxyl 
tertiary chiral center.  These chiral centers induce a certain amount of complexity in the 
proton NMR analyses.  The 13C NMR spectra display six, seven, and eight distinct carbon 
signals corresponding to Diols 1, 2, and 3, respectively (Figure A2).  Although the pendent α-
amino methyl (Diol 1) or methylene (Diol 2 and Diol 3) carbons are diastereotopic, rapid 
nitrogen inversion renders them indistinguishable in the 13C NMR spectra.  The 1H NMR, 13C 
NMR, and high-resolution mass spectrometry data indicated that pure 2-(N,N-
dimethylaminomethyl)-1,4-butanediol, 2-(N,N-diethylaminomethyl)-1,4-butanediol, and 2-
(N,N-dipropylaminomethyl)-1,4-butanediol were synthesized and isolated. 
 102 
 
 
 103 
 
Figure A1.  1H NMR spectra of Diol 1 (top), Diol 2 (middle), and Diol 3 (bottom) 
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Figure A2.  13C NMR spectra for Diol 1 (top), Diol 2 (middle), and Diol 3 (bottom) 
   
Polymer synthesis.  Step growth polymerizations were conducted using Diols 1, 2, 
and 3 and adipoyl chloride, which produced water-soluble PE1, PE2, and PE3, respectively.  
Because of these polymers’ solubility (soluble in MeOH, H2O, DMSO, acetonitrile, and 
DMF; partially soluble in CHCl3 and CH2Cl2; and insoluble in acetone, THF, or toluene), 
 105 
number average molecular weights were analyzed by NMR in D2O: ‹Mn› = 1.4, 1.6, and 2.4× 
103 g/mol for PE1, PE2, and PE3, respectively.    The 1H NMR spectra and 13C spectra for 
PE1, PE2, and PE3 are shown in Figure A3 and Figure A4, respectively.  The polymer 13C 
NMR spectra showed distinguishable 13C signals for the diastereotopic amine substituents, 
which indicated that the nitrogen atoms were protonated during the polymerization. 
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Figure A3.  1H NMR spectra of polymers PE1 (top), PE2 (middle), and PE3 (bottom) 
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Figure A4.  13C NMR of PE1 (top), PE2 (middle), and PE3 (bottom)  
 
 The thermal properties of PE1, PE2, and PE3 are shown in Table A1.  These 
materials were amorphous and possessed glass transition temperatures below 0 °C.  The glass 
transition temperatures increased with decreased alkyl chain length.  Previous studies on 
amine-functionalized gene-delivery vectors reported a similar trend (glass transitions were -
35 °C, -48 °C, and -54 °C for –NMe2, -NEt2, and –NPr2 substituted materials, respectively).5  
 
Table A1.  Thermal properties of amine-functionalized polymers 
 
Sample Tga (°C) 5% wt. lossb (°C) 10% wt. lossb (°C) 
PE1 -1 201 251 
PE2 -19 222 251 
PE3 -21 212 242 
    
aDetermined by DSC analysis.  bDetermined by TGA analysis. 
 
The thermally-responsive behavior of these polymers is currently being investigated, 
including the presence of an upper-critical solution temperature (UCST) or a lower-critical 
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solution temperature (LCST).  Polymers with an UCST or LCST swell or contract in 
solution, respectively, upon the application of heat.  These materials have been used as drug 
delivery scaffolds,6 nonmechanical microfluidic valves,7  immunofluorescent agents,8 and 
gene delivery vectors.9-11 
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1H NMR of poly(diethylene glycol hydromuconate)  (P1) (a’,d’: monomeric HMA) 
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13C NMR of poly(diethylene glycol hydromuconate)  (P1) (b’, e’: monomeric HMA) 
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1H NMR of poly(tetraethylene glycol hydromuconate) (P2) (a’, d’: monomeric HMA) 
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13C NMR of poly(tetraethylene glycol hydromuconate) (P2) (b’, e’: monomeric HMA) 
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1H NMR of poly(diethylene glycol adipate) (P3)  
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13C NMR of poly(diethylene glycol adipate) (P3)  
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1H NMR of poly(tetraethylene glycol adipate) (P4)  
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13C NMR of poly(tetraethylene glycol adipate) (P4)  
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1H NMR of poly(diethylene glycol 4,5-dimethylcyclohex-4-ene cis-1,2-dicarboxylate) (P6)  
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13C NMR of poly(diethylene glycol 4,5-dimethylcyclohex-4-ene cis-1,2-dicarboxylate) (P6)  
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1H NMR of poly(tetraethylene glycol 4,5-dimethylcyclohex-4-ene cis-1,2-dicarboxylate) 
(P7)  
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13C NMR of poly(tetraethylene glycol 4,5-dimethylcyclohex-4-ene cis-1,2-dicarboxylate) 
(P7)  
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FTIR data for polyester prepolymers (P1-P7) 
 
 
Hydroxyl and carbonyl group stretching absorptions in polyester prepolymers. 
Sample Hydroxyl Signal (cm-1) Carbonyl Signal (cm-1) 
P1 3452 1733 
P2 3497 1735 
P3 3523 1732 
P4 3503 1733 
P5 3544 1735 
P6 3464 1731 
P7 3468 1735 
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Dimensions of dogbone mold for Instron testing 
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Water update data for poly(ester urethane)s 
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XPS data for PEU4 
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XPS data for PEU2 
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Table C1.  Number-average molecular weights and r values for PCCD1-PCCD6 
  
Sample ‹Mn› × 10-3 (g/mol)a PDIa rb 
PCCD1 - - 0.600 
PCCD2 1.6 1.9 0.750 
PCCD3 2.5 1.9 0.810 
PCCD4 3.4 1.9 0.867 
PCCD5 4.5 1.7 0.895 
PCCD6 7.7 1.7 0.978 
 
aBased on GPC analysis.  bStoichiometric ratio of CHC to CHM. 
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GPC of PCCD2 
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GPC of PCCD3 
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GPC of PCCD4 
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GPC of PCCD5 
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GPC of PCCD6 
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DSC of PCCD1 
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DSC of PCCD2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 138 
 
 
 
DSC of PCCD3 
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DSC of PCCD4 
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DSC of PCCD5 
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DSC of PCCD6 
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TGA of neat SMP1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 143 
 
 
TGA of extracted SMP1 
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TGA of neat SMP2 
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TGA of extracted SMP2 
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TGA of neat SMP3 
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TGA of extracted SMP3 
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TGA of neat SMP4 
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TGA of extracted SMP4 
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TGA of neat SMP5 
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TGA of extracted SMP5 
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TGA of neat SMP6 
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TGA of extracted SMP6 
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Tan δ curve for extracted SMP2 
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Tan δ curve for neat SMP3 
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Tan δ curve for extracted SMP3 
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Tan δ curve for neat SMP4 
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Tan δ curve for extracted SMP4 
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Tan δ curve for neat SMP5 
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Tan δ curve for extracted SMP5 
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Instron analysis for SMP5 at different temperatures 
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Minocycline Drug Delivery Calibration Curve
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Calibration curves for minocycline samples that were exposed and unexposed to UV 
irradiation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 171 
0
50
100
150
200
250
300
0 1 2 3 4 5 6 7 8
Time (d)
M
as
s 
G
ai
n
 
(w
t %
)
 
Water uptake data for SMP5 (filled diamonds: porous pH = 5; open diamonds: nonporous pH 
= 5; filled circles: porous pH = 7; open circles: nonporous pH = 7) 
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Original “hexnut” pattern 
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Original “hexnut” pattern 
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Original “hexnut” pattern 
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Temporary “cubic” pattern 
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Temporary “cubic” pattern 
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Cubic feature from temporary “cubic” pattern 
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Temporary “cubic” pattern 
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Recovered “hexnut” pattern 
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